<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">NRO</journal-id>
<journal-id journal-id-type="hwp">spnro</journal-id>
<journal-id journal-id-type="nlm-ta">Neuroscientist</journal-id>
<journal-title>The Neuroscientist</journal-title>
<issn pub-type="ppub">1073-8584</issn>
<issn pub-type="epub">1089-4098</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1073858411404948</article-id>
<article-id pub-id-type="publisher-id">10.1177_1073858411404948</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience in Translation</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Neuronal Autophagy as a Mediator of Life and Death</article-title>
<subtitle>Contrasting Roles in Chronic Neurodegenerative and Acute Neural Disorders</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Puyal</surname><given-names>Julien</given-names></name>
<xref ref-type="aff" rid="aff1-1073858411404948">1</xref>
<xref ref-type="fn" rid="fn1-1073858411404948">*</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ginet</surname><given-names>Vanessa</given-names></name>
<xref ref-type="aff" rid="aff1-1073858411404948">1</xref>
<xref ref-type="fn" rid="fn1-1073858411404948">*</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Grishchuk</surname><given-names>Yulia</given-names></name>
<xref ref-type="aff" rid="aff1-1073858411404948">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Truttmann</surname><given-names>Anita C.</given-names></name>
<xref ref-type="aff" rid="aff2-1073858411404948">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Clarke</surname><given-names>Peter G. H.</given-names></name>
<xref ref-type="aff" rid="aff1-1073858411404948">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1073858411404948"><label>1</label>Département de Biologie Cellulaire and de Morphologie (DBCM), Université de Lausanne, Lausanne, Switzerland</aff>
<aff id="aff2-1073858411404948"><label>2</label>Département Médico-Chirurgical de Pédiatrie, Centre Hospitalier Universitaire and Université de Lausanne, Lausanne, Switzerland</aff>
<author-notes>
<corresp id="corresp1-1073858411404948">Julien Puyal, Département de Biologie Cellulaire and de Morphologie (DBCM), Université de Lausanne, Rue du Bugnon 9, 1005 Lausanne, Switzerland Email: <email>JulienPierre.Puyal@unil.ch</email></corresp>
<fn fn-type="other" id="fn1-1073858411404948">
<label>*</label>
<p>These authors contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>6</month>
<year>2012</year>
</pub-date>
<volume>18</volume>
<issue>3</issue>
<fpage>224</fpage>
<lpage>236</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Autophagy is a cellular mechanism for degrading proteins and organelles. It was first described as a physiological process essential for cellular health and survival, and this is its role in most cells. However, it can also be a mediator of cell death, either by the triggering of apoptosis or by an independent “autophagic” cell death mechanism. This duality is important in the central nervous system, where the activation of autophagy has recently been shown to be protective in certain chronic neurodegenerative diseases but deleterious in acute neural disorders such as stroke and hypoxic/ischemic injury. The authors here discuss these distinct roles of autophagy in the nervous system with a focus on the role of autophagy in mediating neuronal death. The development of new therapeutic strategies based on the manipulation of autophagy will need to take into account these opposing roles of autophagy.</p>
</abstract>
<kwd-group>
<kwd>Apoptosis</kwd>
<kwd>neural disorders</kwd>
<kwd>lysosomes</kwd>
<kwd>ischemia</kwd>
<kwd>excitotoxicity</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Autophagy is the process of autodigesting cellular contents in lysosomes. There are three kinds: microautophagy, chaperone-mediated autophagy, and the main type, macroautophagy (<xref ref-type="fig" rid="fig1-1073858411404948">Fig. 1</xref>) (<xref ref-type="bibr" rid="bibr12-1073858411404948">Cuervo 2004</xref>). In this review, we focus on macroautophagy (referred to here simply as autophagy), emphasizing its roles in the survival or death of neurons. Although the term <italic>autophagy</italic> was coined more than 40 years ago, it was neglected for many years but has recently become a subject of intense interest because of the availability of molecular methodologies for inhibiting it. Autophagy plays a physiological role important for cellular growth and differentiation, especially for maintaining cellular homeostasis, which requires the continual turnover of nonfunctional proteins and organelles. There are two main pathways for this turnover. Of these, the ubiquitin-proteasome system is the most important for degrading short-lived proteins, whereas autophagy is the main mechanism for catabolizing long-lived proteins and organelles. Autophagy can also be a survival response in situations of stress, allowing the elimination of toxic metabolites, intracellular pathogens, and damaged proteins and organelles and providing energy and amino acids necessary for vital functions during cellular starvation. However, the induction of excessive (in some sense) autophagy can also lead to cell death. Autophagy plays this paradoxical role in many cell types, including neurons.</p>
<fig id="fig1-1073858411404948" position="float">
<label>Figure 1.</label>
<caption>
<p>Types of autophagy. There are three types of autophagy. <italic>Microautophagy</italic> involves the direct sequestration of a part of the cytosol by the membrane of a lysosome. <italic>Chaperone-mediated autophagy</italic> is specific for proteins carrying a precise sequence of five amino acids (KFERQ). These proteins are taken up by a complex, formed by the chaperone protein (hsc70) and co-chaperones (hip, hop, hsp40, hsp90, and bag1), that directs them to a lysosome where they are recognized by a receptor associated with the lysosomal membrane (LAMP-2A) that recognizes them and causes their translocation to the lysosomal interior. Finally, <italic>macroautophagy</italic>, which is the least selective type of autophagy, involves the sequestration of an entire region of cytosol containing organelles and proteins in a two-membraned vesicle called an autophagosome. The origin of these membranes is not entirely clear, but the process appears to involve the elongation of a membranous structure called the “pre-autophagosome.” The autophagosome then merges with the lysosome to form an <italic>autolysosome</italic> in which the ingested constituents are degraded by the lysosomal enzymes. Thus, macroautophagy generates nucleotides, amino acids, and free fatty acids that can be reused for the synthesis of new macromolecules and energy (ATP).</p>
</caption>
<graphic xlink:href="10.1177_1073858411404948-fig1.tif"/>
</fig>
<sec id="section1-1073858411404948">
<title>Molecular Mechanisms of Macroautophagy</title>
<p>Autophagy was first described in mammalian cells, but its most detailed molecular dissection was in yeast, leading to the discovery of more than 30 genes, designated “atg” for “autophagy-related genes,” that are strongly conserved from yeast to mammals. The above report is simplified, but more detailed accounts are available (<xref ref-type="bibr" rid="bibr27-1073858411404948">He and Klionsky 2009</xref>; <xref ref-type="bibr" rid="bibr19-1073858411404948">Glick and others 2010</xref>; <xref ref-type="bibr" rid="bibr49-1073858411404948">Mehrpour and others 2010</xref>).</p>
<p>The biogenesis of autophagosomes begins with the formation of a pre-autophagosome (or phagophore), a membranous structure containing all the proteins necessary for the creation of an autophagosome, assembled from membranes of preexisting organelles (endoplasmic reticulum, Golgi, mitochondria, plasma membrane) (<xref ref-type="bibr" rid="bibr1-1073858411404948">Axe and others 2008</xref>; <xref ref-type="bibr" rid="bibr26-1073858411404948">Hayashi-Nishino and others 2009</xref>; <xref ref-type="bibr" rid="bibr22-1073858411404948">Hailey and others 2010</xref>; <xref ref-type="bibr" rid="bibr23-1073858411404948">Hamasaki and Yoshimori 2010</xref>; <xref ref-type="bibr" rid="bibr65-1073858411404948">Ravikumar and others 2010</xref>) (<xref ref-type="fig" rid="fig1-1073858411404948">Fig. 1</xref>). This pre-autophagosome undergoes a phase of elongation, then incurvation and end-to-end fusion, to sequester the cytoplasmic constituents to be degraded in the resulting double-membraned autophagosome. As an essential physiological process, autophagy is highly regulated, being held at a low basal level in normal conditions but up-regulated when required. The protein kinase mTOR (mammalian target of rapamycin) is a central actor at the crossroads of different pathways regulating autophagy (<xref ref-type="fig" rid="fig2-1073858411404948">Fig. 2</xref>) (<xref ref-type="bibr" rid="bibr8-1073858411404948">Carrera 2004</xref>; <xref ref-type="bibr" rid="bibr61-1073858411404948">Pattingre and others 2008</xref>). The PI3K-I (phosphoinisitol 3 kinase class I)–AKT/PKB (activator) or AMPK (inhibitor) pathways are indirectly involved in mTOR activity and autophagy regulation. Indeed, the inhibition of mTOR induces the activation of autophagy—for example, following nutrient starvation (the best-known stimulus of autophagy)—enabling the cell to produce metabolites necessary for ATP production and protein synthesis. However, an autophagy induction independent of mTOR can also occur (<xref ref-type="bibr" rid="bibr70-1073858411404948">Sarkar and others 2009</xref>).</p>
<fig id="fig2-1073858411404948" position="float">
<label>Figure 2.</label>
<caption>
<p>Main molecular mechanisms involved in the formation of the autophagosome and in the regulation of autophagy. Different conditions are known to induce autophagy, including hypoxia, reactive oxygen species (ROS) formation, protein aggregation, and, above all, starvation. In fact, decreases in amino acids (aa), in ATP, in insulin, or in growth factor lead to induction of autophagy via the inhibition of mTOR, a central negative regulator of autophagy. mTOR inhibition allows ULK1/2 complex activity, which increases autophagy induction. The process starts with the isolation of a membrane from preexisting organelles such as the endoplasmic reticulum (ER) and the trans-Golgi network (TGN). The PI3K-III/Beclin 1 complex plays a crucial role in the <italic>nucleation</italic> phase. The first step of vesicle nucleation requires the activation of PI3K-III following the formation of a complex containing Atg14L, whereas membrane curvature involves a complex with UVRAG (UV irradiation resistance-associated gene). The elongation phase depends on the combined action of the Atg12-Atg5 and PE-Atg8/LC3 conjugation complexes. The pre-autophagosome elongates, envelops constituents to be degraded, and then closes to form an autophagosome, which usually has a double membrane. LC3-II is the only Atg protein known to be present in autophagosomes (linked to the inner membrane), all the others being removed and recycled. PE = phosphatidylethanolamine.</p>
</caption>
<graphic xlink:href="10.1177_1073858411404948-fig2.tif"/>
</fig>
<p>Autophagy depends on the interaction of different complexes in which each Atg protein has one or several roles to play (<xref ref-type="bibr" rid="bibr49-1073858411404948">Mehrpour and others 2010</xref>; <xref ref-type="bibr" rid="bibr92-1073858411404948">Yang Z and Klionsky 2010</xref>). The most important complexes are the following (<xref ref-type="fig" rid="fig2-1073858411404948">Fig. 2</xref>):</p>
<sec id="section2-1073858411404948">
<title>ULK1-2 complex</title>
<p>In mammalian cells, ULK1/2 (Unc-51-like kinase 1 and 2, Atg1 homologues) forms a stable complex with FIP200 (focal adhesion kinase family-interacting protein 200 kD, Atg17 homologue) and mAtg13 (<italic>mammalian Atg13</italic>). When mTOR is activated, it links to ULK1-2 complex to inhibit its action. In autophagic conditions, mTOR is inhibited and detaches from the complex, leading to activation of mATG13 and FIP200 (<xref ref-type="bibr" rid="bibr25-1073858411404948">Hara and others 2008</xref>). ULK1/2 complex is located on pre-autophagosomal membranes and is thus involved in the induction of autophagy notably by recruiting mAtg9 (<xref ref-type="bibr" rid="bibr31-1073858411404948">Jung and others 2009</xref>; <xref ref-type="bibr" rid="bibr29-1073858411404948">Hosokawa and others 2009</xref>).</p>
</sec>
<sec id="section3-1073858411404948">
<title>PI3KIII–Beclin 1 complex</title>
<p>The PI3K-III (Vps34 homologue) and Beclin 1 (Atg6 homologue) can form two different complexes involving either Atg14L (Atg14-like protein or Barkor) or UVRAG (UV irradiation resistance-associated gene) (<xref ref-type="bibr" rid="bibr45-1073858411404948">Liang and others 2008</xref>; <xref ref-type="bibr" rid="bibr76-1073858411404948">Sun and others 2008</xref>; <xref ref-type="bibr" rid="bibr30-1073858411404948">Itakura and others 2008</xref>). Both complexes contribute to the first stage of autophagosome formation. The Atg14L complex plays a role in the recruitment of the complexes Atg12-Atg5 and PE-Atg8/LC3 (see below) at the level of the pre-autophagosomal membrane. UVRAG complex permits the incurvation of the pre-autophagosome (<xref ref-type="bibr" rid="bibr78-1073858411404948">Takahashi and others 2009</xref>).</p>
</sec>
<sec id="section4-1073858411404948">
<title>LC3-PE conjugate</title>
<p>Atg8 has several homologues in mammals: GABARAP (γ-aminobutyric acid type A receptor-associated protein), GATE-16 (Golgi-associated ATPase enhancer of 16 kDa), mAtg8L, and the most studied, LC3 (microtubule-associated protein 1 light chain 3, A and B). Cytosolic LC3 is first synthesized as a pro-LC3, proteolytically converted to LC3-I form, and finally conjugated to a phosphatidylethanolamine (PE), which is an abundant phospholipid in membranes. As a result, LC3 is incorporated into a pre-autophagosomal membrane (<xref ref-type="bibr" rid="bibr17-1073858411404948">Geng and Klionsky 2008</xref>). This posttranscriptional form, LC3-II, seems to be involved in the elongation process and the closure of the autophagosome (<xref ref-type="bibr" rid="bibr51-1073858411404948">Nakatogawa and others 2007</xref>).</p>
</sec>
<sec id="section5-1073858411404948">
<title>Atg12-Atg5 conjugate</title>
<p>Atg12 and Atg5 form a complex that binds Atg16L (homologue of Atg16) via Atg5. By oligomerization, Atg16L forms larger complexes linked to the pre-autophagosomal membrane that are essential for the elongation process (<xref ref-type="bibr" rid="bibr50-1073858411404948">Mizushima and others 2003</xref>). The presence of this complex is also indispensable for recruitment of the LC3-PE conjugate (<xref ref-type="bibr" rid="bibr46-1073858411404948">Longatti and Tooze 2009</xref>).</p>
</sec>
<sec id="section6-1073858411404948">
<title>mAtg9 complex</title>
<p>mAtg9 is a transmembrane protein localized in the trans-Golgi network, late endosomes, and notably in the pre-autophagosomal membrane. One function of mAtg9 could be the recruitment of the membrane lipids and proteins necessary for the elongation step (Atg12-Atg5 and LC3-PE) (<xref ref-type="bibr" rid="bibr87-1073858411404948">Webber and others 2007</xref>).</p>
<p>Most proteins involved in the biogenesis of autophagosomes are removed from the autophagosome once it has been fully formed, probably to be recycled for subsequent use (<xref ref-type="bibr" rid="bibr67-1073858411404948">Reggiori and others 2004</xref>; <xref ref-type="bibr" rid="bibr44-1073858411404948">Legakis and others 2007</xref>). For this reason, autophagosome-specific proteins are few. The best known is LC3-II, which is the most widely used marker for revealing the presence of autophagosomes (<xref ref-type="bibr" rid="bibr32-1073858411404948">Kabeya and others 2000</xref>).</p>
<p>Once the autophagosome has been fully formed, it can fuse with a lysosome. In mammals, the fusion process is complex and requires a series of maturation steps before the autophagosome can be transported to the lysosome. Little is known of these steps, but the microtubules seem to play a role (<xref ref-type="bibr" rid="bibr86-1073858411404948">Webb and others 2004</xref>). The proteins necessary for fusion include proteins involved in other types of transport: vesicular proteins such as certain GTPases (Rab22, Rab24, Rab7), soluble N-ethylmaleimide-sensitive factor activating protein receptor (SNARE) proteins, and the protein NSF (N-ethylmaleimide-sensitive fusion protein) (<xref ref-type="bibr" rid="bibr81-1073858411404948">Wang CW and Klionsky 2003</xref>). Once the fusion has occurred, the acidic environment of the lysosome permits the autophagosome to be degraded by lysosomal enzymes, thus producing degradation products that can be recycled for protein synthesis and energy production.</p>
<p>Because the rest of this review addresses the effects of changes in autophagy, it is important to realize that a change in the number of autophagosomes is not on its own an unambiguous indicator of the level of autophagy. For example, the increased abundance of autophagosomes in Alzheimer disease has been shown to be the result of a defect in the fusion of autophagosomes to lysosomes (<xref ref-type="bibr" rid="bibr57-1073858411404948">Nixon 2007</xref>). Various approaches are available to resolve this ambiguity. In experiments in vitro, it is usually possible to measure the rate of autophagic flux (<xref ref-type="bibr" rid="bibr35-1073858411404948">Klionsky and others 2008</xref>). In vivo this may be difficult, but if the numbers of autolysosomes as well as autophagosomes can be shown to have increased, this is an indication that autophagic flux has increased (<xref ref-type="bibr" rid="bibr63-1073858411404948">Puyal and others 2009</xref>). Study of the degradation of specific autophagic substrate as p62/SQSTM1 (<xref ref-type="bibr" rid="bibr60-1073858411404948">Pankiv and others 2007</xref>) and additional treatment with lysosomal inhibitors to see if the markers accumulate could be complementary strategies to validate an increase in autophagic flux.</p>
</sec>
</sec>
<sec id="section7-1073858411404948">
<title>Autophagy in Chronic Neurodegenerative Diseases</title>
<p>In healthy neurons, it is generally difficult to detect autophagosomes. One reason for this might be that neurons are privileged cells, strongly protected by their own adaptive mechanisms and by glial cells against stimuli that induce autophagy strongly in other systems (e.g., nutrient deprivation). But that does not mean that autophagy is unimportant to neurons. One reason for the rarity of autophagosomes in neurons could be that the process of autophagy is so efficient that few are needed in normal conditions (<xref ref-type="bibr" rid="bibr58-1073858411404948">Nixon and others 2005</xref>). In the long term, autophagy is essential for neuronal health, and insufficient autophagy appears to be a contributing factor in chronic neurodegenerative diseases. Knockout mice lacking Atg5 or Atg7 specifically in neurons rapidly develop symptoms of neurodegenerative diseases, with the presence of inclusions in neurons (<xref ref-type="bibr" rid="bibr37-1073858411404948">Komatsu and others 2006</xref>; <xref ref-type="bibr" rid="bibr24-1073858411404948">Hara and others 2006</xref>). Moreover, basal autophagy is essential for maintaining axon homeostasis and morphology, and its loss of function leads to axonal swelling, followed by progressive neurodegeneration (<xref ref-type="bibr" rid="bibr54-1073858411404948">Nishiyama and others 2007</xref>; <xref ref-type="bibr" rid="bibr39-1073858411404948">Komatsu and others 2007</xref>).</p>
<sec id="section8-1073858411404948">
<title>Neurodegenerative Diseases: The Consequences of Reduced Autophagy?</title>
<p>These roles of autophagy are important in neurodegenerative disease development. A common characteristic of many neurodegenerative diseases is the accumulation of mutated or toxic proteins and their aggregation. These diseases are characterized by proteinopathies and include notably Parkinson disease (aggregates of α-synuclein), Huntington disease (aggregates of polyglutamine), Alzheimer disease (aggregates of the peptide β-amyloid resulting from a faulty cleavage of the protein APP [amyloid precursor protein]), tauopathies (aggregates of hyperphosphorylated protein tau), or bovine spongiform encephalopathies. In all these different illnesses, the presence of excessive numbers of autophagosomes and autolysosomes has been shown in degenerating neurons (<xref ref-type="bibr" rid="bibr68-1073858411404948">Rubinsztein and others 2005</xref>). However, in these chronic neurodegenerative diseases, autophagy seems to play a protective role, degrading mutated or toxic proteins, and does not appear to be mediating cell death. In particular, the enhanced autophagy may be compensating for a deficiency in proteasome activity (<xref ref-type="bibr" rid="bibr59-1073858411404948">Pandey and others 2007</xref>). An Alzheimer-related mutation of presenilin-1 has been shown to cause a deficiency in autophagic clearance and may be the cause of pathogenic protein accumulations and neuronal cell death in Alzheimer disease (<xref ref-type="bibr" rid="bibr43-1073858411404948">Lee and others 2010</xref>). Mutation of the protein Parkin, which is recruited to dysfunctional mitochondria and involved in the signal for mitophagy (selective degradation of mitochondria by autophagy), has been implicated in the pathogenesis of Parkinson disease (<xref ref-type="bibr" rid="bibr52-1073858411404948">Narendra and others 2008</xref>).</p>
</sec>
<sec id="section9-1073858411404948">
<title>Stimulating Autophagy to Prevent Neurodegeneration?</title>
<p>The use of pharmacological agents modifying autophagy has tended to confirm its protective role in neurodegenerative diseases associated with proteinopathies. Thus, inhibitors of autophagy such as 3-methyladenine (3-MA) or bafilomycin A1 diminish the degradation of aggregates, whereas inductors of autophagy such as rapamycin increase their elimination and reduce their toxicity (<xref ref-type="bibr" rid="bibr64-1073858411404948">Ravikumar and others 2002</xref>; <xref ref-type="bibr" rid="bibr85-1073858411404948">Webb and others 2003</xref>). A good example is Huntington disease, which is characterized by the abnormal production of polyQ polymers due to a mutation of the gene encoding the protein huntingtin and their accumulation in the form of insoluble aggregates. Not only does rapamycin treatment attenuate the toxicity of polyQ in cell culture models, but in some animal models of Huntington disease involving the overexpression of polyQ, it prevents neurodegeneration and enhances behavioral performance (<xref ref-type="bibr" rid="bibr66-1073858411404948">Ravikumar and others 2004</xref>). More recently, it has been shown that stimulation of lysosomal cathepsin activities in the Alzheimer mouse model TgCRND8 can decrease extracellular amyloid deposition and prevent deficits in learning and memory (<xref ref-type="bibr" rid="bibr91-1073858411404948">Yang DS and others 2011</xref>).</p>
<p>Thus, the stimulation of autophagy seems to be a promising neuroprotective strategy for neurodegenerative diseases associated with proteinopathies, although it remains to be determined whether the optimal treatment will target early (autophagosomal), late (autolysosomal), or both stages of the autophagic process. Nevertheless, the treatment would need to be moderate because excessive autophagy can be destructive, as discussed below.</p>
</sec>
</sec>
<sec id="section10-1073858411404948">
<title>Autophagy in Neuronal Death</title>
<p>Despite the life-promoting roles of autophagy, it is also associated with cell death, and the term <italic>autophagic (or type 2) cell death</italic> is frequently used to refer to dying cells containing numerous autophagosomes and autolysosomes (many early studies showed only autolysosomes). This is frequently observed during embryonic development and is probably the most common type of cell death in insect metamorphosis (<xref ref-type="bibr" rid="bibr10-1073858411404948">Clarke 1990</xref>), but autophagic features are also associated with many cases of pathological cell death ranging from heart failure (<xref ref-type="bibr" rid="bibr84-1073858411404948">Wang ZV and others 2010</xref>) to the death of cancer cells due to chemotherapy (<xref ref-type="bibr" rid="bibr93-1073858411404948">Yousefi and Simon 2009</xref>).</p>
<sec id="section11-1073858411404948">
<title>Early Studies Relating Autophagy to Cell Death in Neurons</title>
<p>Cell death with autophagic characteristics is also observed in neurons. It generally occurs when there is massive cell death in a particular region, whereas the cells die by apoptosis when they are scattered among other cells that do not die (<xref ref-type="bibr" rid="bibr10-1073858411404948">Clarke 1990</xref>). Thus, neuronal death during metamorphosis has a strong autophagic component (<xref ref-type="bibr" rid="bibr71-1073858411404948">Schweichel and Merker 1973</xref>; <xref ref-type="bibr" rid="bibr10-1073858411404948">Clarke 1990</xref>). For example, Rohon-Beard cells in the spinal cords of frog tadpoles die by “autophagic cell death” (<xref ref-type="bibr" rid="bibr42-1073858411404948">Lamborghini 1987</xref>).</p>
<p>In most vertebrates, the most pronounced phase of neuronal death occurs relatively late, when synaptic connections are being formed. During this period, the neurons are highly dependent on retrograde (and anterograde) neurotrophic support, and numerous studies of neuronal death in development have involved axotomy or other means of depriving neurons of retrograde support. In some cases, the resulting neuronal death had autophagic characteristics, but in many others, it clearly did not. Developmental maturity appears to be an important factor determining the type of neuronal death. Thus, the death of axotomized motoneurons in larval frogs was found to have a “pyknotic” (apoptosis-like) morphology when the axotomy was performed in very young tadpoles, whereas very late axotomy caused classic chromatolysis. But axotomy at an intermediate stage caused the “genesis of numerous secondary lysosomes in degenerating cells”—in other words, cell death with an autophagic morphology (<xref ref-type="bibr" rid="bibr13-1073858411404948">Decker 1978</xref>). Studies in chick embryos on the isthmo-optic nucleus, which is the source of the brain’s centrifugal projection to the retina in birds, showed an age dependence that was similar to the above but not quite so clear-cut (<xref ref-type="bibr" rid="bibr11-1073858411404948">Clarke and Hornung 1989</xref>).</p>
<p>The above examples of autophagic responses in dying neurons suggested that autophagy might play a role in mediating the cell death, but this needs to be demonstrated by testing the effects of autophagy inhibition. Many of these experiments used nonneuronal cells, especially cell lines, and we need to take these into account.</p>
</sec>
<sec id="section12-1073858411404948">
<title>Autophagy as a Mediator of Cell Death</title>
<p>There are three principal morphological types of cell death: type 1 or apoptosis, type 2 or autophagic cell death, and type 3, which includes several subtypes of which the best known is necrosis (<xref ref-type="bibr" rid="bibr10-1073858411404948">Clarke 1990</xref>). The term <italic>autophagic cell death</italic> refers to a type of programmed cell death that is morphologically different from apoptosis, being characterized by the presence of numerous autophagosomes and autolysosomes, as has been described in many cell types, including neurons, during brain development (<xref ref-type="bibr" rid="bibr71-1073858411404948">Schweichel and Merker 1973</xref>; <xref ref-type="bibr" rid="bibr10-1073858411404948">Clarke 1990</xref>). It involves the destruction of organelles in autolysosomes. The cytoskeleton (<xref ref-type="bibr" rid="bibr6-1073858411404948">Bursch and others 2000</xref>) and nucleus are initially preserved, but ultimately even the nucleus is sometimes found to be destroyed in lysosomes (<xref ref-type="bibr" rid="bibr10-1073858411404948">Clarke 1990</xref>; <xref ref-type="bibr" rid="bibr20-1073858411404948">Gonzalez-Martin and others 1992</xref>).</p>
<p>The presence of autophagic features in dying cells has been variously interpreted to reflect a death-mediating role of autophagy or, conversely, an attempt by the cell to protect itself against the death-mediating stimulus. Even in recent years, the death-mediating role of autophagy remains contested by some (<xref ref-type="bibr" rid="bibr40-1073858411404948">Kroemer and Levine 2008</xref>). The fact that autophagy in dying cells often destroys a considerable part of the cell, including sometimes the nucleus, was long ago interpreted to indicate that autophagy must be death promoting (<xref ref-type="bibr" rid="bibr28-1073858411404948">Hornung and others 1989</xref>; <xref ref-type="bibr" rid="bibr10-1073858411404948">Clarke 1990</xref>). This interpretation was supported by numerous reports since 1992 of autophagy inhibition using 3-methyladenine and related inhibitors that were protective against cell death in numerous situations where it was characterized by an autophagic morphology (<xref ref-type="bibr" rid="bibr69-1073858411404948">Sandvig and van Deurs 1992</xref>; <xref ref-type="bibr" rid="bibr90-1073858411404948">Xue and others 1999</xref>), but the interpretation was clouded by the fact that the inhibitors were not specific for autophagy. The inhibition of autophagy by 3-methyladenine is due to its inhibition of phosphoinositide 3–kinase (PI3K) (<xref ref-type="bibr" rid="bibr4-1073858411404948">Blommaart and others 1997</xref>), including the class III PI3K (VPS34), which is necessary for autophagy; more specific PI3K inhibitors such as LY294002 likewise inhibit autophagic cell death (<xref ref-type="bibr" rid="bibr21-1073858411404948">Guillon-Munos and others 2005</xref>). But none of these PI3K inhibitors is specific for autophagy, partly because they inhibit the class I family of PI3Ks as well as the class III, as has recently been confirmed for 3-methyladenine (<xref ref-type="bibr" rid="bibr89-1073858411404948">Wu and others 2010</xref>). Conclusive evidence for a death-mediating role of the autophagy required more specific inhibition, necessitating molecular techniques.</p>
<p>The first molecular confirmations that autophagy can be directly responsible for cell death were provided in 2004 by two studies employing RNA interference for the knockdown of autophagy genes (Atg5, 6, or 7) in cells incapable of undergoing apoptosis. In one of these studies, fibroblasts genetically modified so as to be unable to express proapoptotic Bax and Bak underwent cell death dependent on autophagy genes Atg5 and Beclin 1 when they were exposed to apoptotic inductors (<xref ref-type="bibr" rid="bibr75-1073858411404948">Shimizu and others 2004</xref>). In the other study, the pharmacological inhibition of caspases, particularly proapoptotic caspase-8, led to programmed cell death that could be blocked by the knockdown of Atg7 and Beclin 1 (<xref ref-type="bibr" rid="bibr94-1073858411404948">Yu and others 2004</xref>). Thus, when apoptosis is disactivated, cells can die by a purely autophagic death pathway.</p>
<p><xref ref-type="bibr" rid="bibr40-1073858411404948">Kroemer and Levine (2008)</xref> have objected that the use of apoptosis-incompetent cells is a too artificial situation for its results to be extended to practically relevant situations where apoptosis is functional, but numerous recent studies have confirmed that the knockdown of atg5, atg6, or atg7 is protective against cell death in many conditions and cell types, including cells either competent or incompetent for apoptosis (<xref ref-type="bibr" rid="bibr9-1073858411404948">Chen and others 2008</xref>; <xref ref-type="bibr" rid="bibr93-1073858411404948">Yousefi and Simon 2009</xref>; <xref ref-type="bibr" rid="bibr33-1073858411404948">Kandouz and others 2010</xref>). Kroemer and Levine have also argued that the use of siRNA-mediated knockdown of atg genes may not be sufficiently specific for valid interpretation, but resistance to cell death has also been obtained in mice with cell-specific deletion of atg5 or atg7 or in embryonic fibroblasts from these mice (<xref ref-type="bibr" rid="bibr80-1073858411404948">Wan and others 2008</xref>). This is true also in neurons (<xref ref-type="bibr" rid="bibr79-1073858411404948">Uchiyama and others 2009</xref>), as discussed in more detail below. Thus, there is now considerable evidence that autophagic pathways can mediate cell death in practically relevant situations.</p>
<p>But even if this is accepted, the detailed mechanism is still unclear. Is autophagic digestion in autolysosomes the death-mediating event, or does an earlier stage of autophagy kill by pathways independent of lysosomes? If intralysosomal digestion is responsible, does it kill by devouring a large portion of the cell (<xref ref-type="bibr" rid="bibr10-1073858411404948">Clarke 1990</xref>) or by destroying a particular cellular defense system, such as the antioxidant system (<xref ref-type="bibr" rid="bibr95-1073858411404948">Yu and others 2006</xref>), or in other ways? Alternatively, lysosomes might kill by a process distinct from autophagy sensu stricto, such as lysosomal permeabilization, leading to the release of hydrolytic enzymes as has been claimed in various situations, including recently a model of Parkinson disease (<xref ref-type="bibr" rid="bibr15-1073858411404948">Dehay and others 2010</xref>). These questions remain open in most models.</p>
<p>A further complication for understanding the role of autophagy in cell death is that several death pathways may be activated in the same cell. In such cases, even if autophagy has been shown to be death mediating, it cannot immediately be assumed that cell death is of the autophagic type because autophagy can in some cases trigger apoptosis. The ambiguity is due to the fact that apoptosis and autophagy are regulated by common mediators, and the activation of one can modify the other (<xref ref-type="bibr" rid="bibr48-1073858411404948">Maiuri and others 2007</xref>). This question is discussed in more detail below, in the context of excitotoxicity and cerebral ischemia.</p>
</sec>
</sec>
<sec id="section13-1073858411404948">
<title>Autophagy in Excitotoxicity and Acute Neural Disorders</title>
<sec id="section14-1073858411404948">
<title>Activation of Autophagy in Conditions Involving Excitotoxicity</title>
<p>Excitotoxicity, a phenomenon induced by excessive stimulation, usually by the overactivation of excitatory amino acid (glutamate) receptors, is the main mediator of neuronal death in numerous pathologies of the nervous system, including cerebral ischemia and traumatic brain injury. The induction of autophagy has been shown in several acute excitotoxicity models, including the application of <italic>N</italic>-methyl-D-aspartate (NMDA) onto organotypic hippocampal slices (<xref ref-type="bibr" rid="bibr5-1073858411404948">Borsello and others 2003</xref>) and the direct in vivo injection of kainate into the brains of mice (<xref ref-type="bibr" rid="bibr74-1073858411404948">Shacka and others 2007</xref>). Autophagy has also been reported in chronic excitotoxicity models, notably in the lurcher mouse, in which cerebellar Purkinje cells undergo constitutive depolarization (<xref ref-type="bibr" rid="bibr96-1073858411404948">Yue and others 2002</xref>). However, the depolarization appears not to be the sole cause of the pathology (<xref ref-type="bibr" rid="bibr72-1073858411404948">Selimi and others 2003</xref>), and the induced autophagy appears not to mediate the cell death in the lurcher (<xref ref-type="bibr" rid="bibr53-1073858411404948">Nishiyama and others 2010</xref>).</p>
<p>An increase in Beclin 1 expression has been described in traumatic brain (<xref ref-type="bibr" rid="bibr16-1073858411404948">Erlich and others 2006</xref>) and spinal cord injuries (<xref ref-type="bibr" rid="bibr34-1073858411404948">Kanno and others 2009</xref>). In the cerebral cortex, traumatic brain injury has been shown to induce the translocation of Beclin 1 out of membrane microdomains containing NMDA receptor subunit NR2B and PSD95, with resultant stimulation of autophagy (<xref ref-type="bibr" rid="bibr3-1073858411404948">Bigford and others 2009</xref>).</p>
<p>The first study showing an activation of autophagy after cerebral ischemia was that by Nitatori and colleagues (<xref ref-type="bibr" rid="bibr56-1073858411404948">Nitatori and others 1995</xref>; <xref ref-type="bibr" rid="bibr55-1073858411404948">Nitatori and others 1996</xref>), who detected by electron microscopy the presence of numerous autophagic vacuoles and an increase in the size of vesicles positive for cathepsin B in hippocampal CA1 neurons three days after ischemia. Several subsequent studies on cerebral ischemia have shown increases in the activation and expression of lysosomal proteases, increased expression of autophagosomal marker LC3-II, and increases in the numbers of morphologically identified autophagosomes (<xref ref-type="bibr" rid="bibr73-1073858411404948">Seyfried and others 1997</xref>; <xref ref-type="bibr" rid="bibr97-1073858411404948">Zhu and others 2005</xref>; <xref ref-type="bibr" rid="bibr14-1073858411404948">Degterev and others 2005</xref>; <xref ref-type="bibr" rid="bibr88-1073858411404948">Wen and others 2008</xref>; <xref ref-type="bibr" rid="bibr63-1073858411404948">Puyal and others 2009</xref>). Similar changes are found in rodent neonatal cerebral hypoxia-ischemia, which is a model of perinatal asphyxia (<xref ref-type="bibr" rid="bibr97-1073858411404948">Zhu and others 2005</xref>; <xref ref-type="bibr" rid="bibr98-1073858411404948">Zhu and others 2006</xref>; <xref ref-type="bibr" rid="bibr18-1073858411404948">Ginet and others 2009</xref>).</p>
</sec>
<sec id="section15-1073858411404948">
<title>Neuroprotection by Inhibition of Autophagy In Vivo</title>
<p>Even though the activation of autophagy has been clarified in several excitotoxicity models, the role of autophagy in the associated neuronal death still needed to be defined for each pathological situation. Over the past three years, this has begun to be clarified by the inhibition of autophagy using pharmacological and molecular approaches.</p>
<p>Recent studies involving striatal injections of kainate (<xref ref-type="bibr" rid="bibr83-1073858411404948">Wang Y and others 2008</xref>) or quinolate (<xref ref-type="bibr" rid="bibr82-1073858411404948">Wang Y and others 2009</xref>) showed neuroprotection by 3-MA, suggesting a role of autophagy in mediating the neuronal death. However, apoptotic markers (p53, PUMA, Bax, caspase-3) were also reduced by 3-MA, raising questions about the relationship between autophagy and apoptosis in the mediation of the cerebral damage (<xref ref-type="bibr" rid="bibr83-1073858411404948">Wang Y and others 2008</xref>).</p>
<p>Similar protection has been obtained with 3-MA in various focal cerebral ischemia models. Both in adult rats (<xref ref-type="bibr" rid="bibr88-1073858411404948">Wen and others 2008</xref>) and in neonatal rats (<xref ref-type="bibr" rid="bibr63-1073858411404948">Puyal and others 2009</xref>), focal ischemia enhanced morphological and biochemical markers of autophagy and lysosomal activation; in both models, 3-MA diminished all these effects and provided substantial neuroprotection. In the neonatal study, inhibition with 3-MA was also found to reduce several apoptotic markers (<xref ref-type="fig" rid="fig3-1073858411404948">Fig. 3</xref>): activation of caspase-3 and caspase-9 and the translocation of apoptosis-inducing factor (AIF) to the nucleus (<xref ref-type="bibr" rid="bibr63-1073858411404948">Puyal and others 2009</xref>). However, inhibition of autophagy was proven to be a more promising strategy for postischemic neuroprotection than caspase inhibition, which failed to decrease the cerebral lesion.</p>
<fig id="fig3-1073858411404948" position="float">
<label>Figure 3.</label>
<caption>
<p>Neuroprotection against neonatal stroke damage by postischemic autophagy inhibition. (<italic>A</italic>) Neuroprotective effect on lesion volume after 24 hours of reperfusion of postischemic administration of the autophagy inhibitor 3-methyladenine (3-MA) injected at different times after the ischemic insult. 3-MA induced a substantial and significant reduction of the infarct volume when injected 0, 3, or 6 hours after ischemia, as compared to saline. Data represent mean ± SEM. **<italic>P</italic> &lt; .01. (<italic>B</italic>) Cresyl violet-stained sections showing representative brain injuries after intracerebroventricular injections of saline (left panel) or 3-MA 0 hours (<italic>right panel</italic>) at the level of the hippocampus after 24 hours of reperfusion. Bar = 1 mm. (<italic>C</italic>) Effect of 3-MA treatment on caspase-3 activation. <italic>Upper panel</italic>: Representative immunoblot of cleaved caspase-3 in extracts of ischemic cortex at 24 hours of reperfusion from rats treated with 3-MA or saline. <italic>Lower panel</italic>: Quantification of cleaved caspase-3 in the 3-MA-treated and saline-treated rats (n &gt; 5 per group). CL, contralateral; IL, ipsilateral. (<italic>D</italic>) 3-MA treatment strongly reduced the number of cells positive for cleaved caspase-9 (<italic>upper panel</italic>) and the number of apoptosis-inducing factor (AIF)–positive nuclei (<italic>lower panel</italic>) in the ischemic cortex at 24 hours compared to rats treated with saline. Data represent mean ± SEM. Comparisons by <italic>t</italic> test with saline. **<italic>P</italic> &lt; .01. Adapted from <xref ref-type="bibr" rid="bibr63-1073858411404948">Puyal and others (2009)</xref>.</p>
</caption>
<graphic xlink:href="10.1177_1073858411404948-fig3.tif"/>
</fig>
<p>In view of the limited specificity of 3-MA, it is important to confirm the pharmacological results using more specific molecular methodologies. The most relevant studies for cerebral hypoxia-ischemia have focused on Atg7. Because the global deletion of atg7 is lethal soon after birth (<xref ref-type="bibr" rid="bibr41-1073858411404948">Kuma and others 2004</xref>; <xref ref-type="bibr" rid="bibr38-1073858411404948">Komatsu and others 2005</xref>), <xref ref-type="bibr" rid="bibr36-1073858411404948">Koike and others (2008)</xref> resorted to the use of conditional knockout mice (<italic>Atg7<sup>flox/flox</sup></italic>: nestin<italic>-Cre</italic>) in which atg7 is deleted specifically in CNS tissue. In a detailed study on neonatal hypoxia-ischemia (at P7), they characterized the activation of apoptotic (e.g., caspase-3) and autophagic pathways, showing, in particular, an increase in autophagosomal marker LC3-II and of autophagosomes/autolysosomes as identified by electron microscopy. Importantly, in these <italic>atg7</italic> conditional knockout mice, the hippocampus was almost completely resistant to the hypoxia-ischemia, and caspase-3 activation was prevented.</p>
<p>Thus, the weight of evidence strongly supports the view that autophagy plays a pro-death role in acute neural disorders. This view was, however, challenged by <xref ref-type="bibr" rid="bibr7-1073858411404948">Carloni and others (2008)</xref>, who found that rapamycin (an inducer of autophagy) was neuroprotective in neonatal rats exposed to hypoxia-ischemia, whereas 3-MA did not affect the lesion size. However, the effects of these treatments on autophagy were verified only from their effect on Beclin 1 expression, which is not a direct measure of autophagy, and the dose of 3-MA injected by Carloni and others was eight times lower than the minimal effective dose for reducing the level of LC3-II when injected intracerebroventricularly in P12 rats (<xref ref-type="bibr" rid="bibr63-1073858411404948">Puyal and others 2009</xref>) or adult rats (<xref ref-type="bibr" rid="bibr88-1073858411404948">Wen and others 2008</xref>). Furthermore, rapamycin is an inhibitor of mTOR, which affects processes other than autophagy, notably cell growth and proliferation, and protein synthesis (<xref ref-type="bibr" rid="bibr77-1073858411404948">Swiech and others 2008</xref>). For these above reasons, the results of Carloni and others do not demonstrate a pro-survival role of autophagy in neonatal hypoxia-ischemia, and complementary evidence is needed.</p>
</sec>
<sec id="section16-1073858411404948">
<title>Relationships between Autophagy and Apoptosis</title>
<p>Research on cell lines indicates that apoptosis and autophagy are regulated by common mediators, and there are multiple routes for crosstalk between apoptotic and autophagic signaling pathways (<xref ref-type="bibr" rid="bibr48-1073858411404948">Maiuri and others 2007</xref>). For instance, caspase-3 can inhibit autophagy by cleaving Beclin 1 (<xref ref-type="bibr" rid="bibr47-1073858411404948">Luo and Rubinsztein 2010</xref>), and the knockdown of caspase-3 can induce cell death with autophagic characteristics (<xref ref-type="bibr" rid="bibr2-1073858411404948">Bialik and others 2010</xref>), as can the inhibition of caspase-8 (<xref ref-type="bibr" rid="bibr94-1073858411404948">Yu and others 2004</xref>). It has also been shown that a caspase-cleavage product of Atg5 can be translocated from the cytosol to mitochondria, where it interferes with the inhibitory action of Bcl-xL on Bax and hence triggers cytochrome c release and caspase activation (<xref ref-type="bibr" rid="bibr93-1073858411404948">Yousefi and Simon 2009</xref>). It would be beyond our present scope to discuss this cell biological literature in detail, and we focus here on autophagy-apoptosis interactions in neurons.</p>
<p>In many cases of excitotoxicity, dying neurons expressed both apoptotic and autophagic features as following neonatal hypoxia-ischemia (<xref ref-type="bibr" rid="bibr36-1073858411404948">Koike and others 2008</xref>; <xref ref-type="bibr" rid="bibr18-1073858411404948">Ginet and others 2009</xref>). Moreover, the apoptotic and autophagic pathways appeared to interact. For example, several apoptotic markers were reduced by 3-MA in two studies (<xref ref-type="bibr" rid="bibr83-1073858411404948">Wang Y and others 2008</xref>; <xref ref-type="bibr" rid="bibr63-1073858411404948">Puyal and others 2009</xref>), and caspase-3 activation was prevented in the neuron-specific <italic>atg7</italic> knockout mice in another study (<xref ref-type="bibr" rid="bibr36-1073858411404948">Koike and others 2008</xref>). This raises the question whether the neuronal death mediated by autophagy is true autophagic cell death (independent of apoptosis) or whether it is autophagy-mediated apoptosis (<xref ref-type="bibr" rid="bibr62-1073858411404948">Puyal and Clarke 2009</xref>).</p>
<p>Comparison of the cell death in two different brain regions suggests that both possibilities may be true, depending on the region. <xref ref-type="bibr" rid="bibr18-1073858411404948">Ginet and others (2009)</xref> compared the process of neuronal death in hippocampal CA1 and CA3, as well as in the cerebral cortex, in a severe model of neonatal hypoxia-ischemia in P7 rats (<xref ref-type="bibr" rid="bibr18-1073858411404948">Ginet and others 2009</xref>). In the cortex, the classical morphologies of pure autophagic (type II) or apoptotic (type I) cell death were never observed; the morphologies were always a mixture of the two. Nevertheless, neurons with strong autophagic activity showed only moderate apoptotic features: They showed only moderate chromatin condensation, were only sometimes positive for activated caspase-3 (more frequently near the center of the lesion), and were never positive for a DNA fragmentation assay (terminal deoxynucleotidyl transferase dUTP nick end labeling [TUNEL], which tends to show apoptotic neurons, although it is not rigorously specific). These observations are compatible with the interpretation that autophagy occurs upstream of apoptosis, and in a related neonatal model, focal cerebral ischemia at P12, inhibition of autophagy with 3-MA reduced apoptotic features (<xref ref-type="bibr" rid="bibr63-1073858411404948">Puyal and others 2009</xref>).</p>
<p>In contrast, in the hippocampus, apoptosis and autophagy appeared to be segregated according to the hippocampal region. In CA1, the dying neurons had a frankly apoptotic (and partly necrotic) ultrastructure and were positive for caspase-3, whereas those in CA3 strongly expressed autophagic and lysosomal markers (punctate LC3, LAMP1, cathepsin D) and exhibited a strongly autophagic ultrastructure (<xref ref-type="bibr" rid="bibr18-1073858411404948">Ginet and others 2009</xref>). This segregation indicates that neuronal apoptosis (or mixed apoptosis-necrosis) present in hypoxia-ischemia can occur without being triggered by autophagy and that neuronal death with strong autophagic features can be mediated without the need for caspase-dependent apoptosis (<xref ref-type="fig" rid="fig4-1073858411404948">Fig. 4</xref>).</p>
<fig id="fig4-1073858411404948" position="float">
<label>Figure 4.</label>
<caption>
<p>Regional differences in the involvement of autophagy and apoptosis in mediating neuronal death in the lesioned hippocampus after neonatal hypoxia-ischemia. (<italic>A</italic>) LAMP1 immunolabeling is strongly increased in CA3, whereas (<italic>B</italic>) cleaved caspase-3 is restricted to CA1 and the dentate gyrus. Bars: 0.5 mm or 50 µm in high magnifications. (<italic>C</italic>) Electron micrographs of CA3 neurons at 24 hours show large numbers of autophagosomes in the cytosol. At higher magnification, note the presence of double-membrane structures encircling organelles (white arrowheads) and the presence of autolysosomes (black arrowheads). The nucleus (n) of such CA3 neurons shows very little, if any, chromatin condensation. Bar: 1 µm. (<italic>D</italic>) Electron micrographs of CA1 neurons at 24 hours after hypoxia ischemia show a hybrid phenotype of cell death with a mixture of necrotic and apoptotic features, including plasma membrane rupture, chromatin condensation in the nucleus (n), and swelling of organelles, as observed at high magnification. Bar: 1 µm. Adapted from <xref ref-type="bibr" rid="bibr18-1073858411404948">Ginet and others (2009)</xref>.</p>
</caption>
<graphic xlink:href="10.1177_1073858411404948-fig4.tif"/>
</fig>
</sec>
</sec>
<sec id="section17-1073858411404948">
<title>Conclusions</title>
<p>Autophagy is a physiological mechanism indispensable for correct development and for the health of neurons by its different roles in quality control for proteins and organelles and as an energy supplier (<xref ref-type="fig" rid="fig5-1073858411404948">Fig. 5</xref>). The role of its induction in conditions of stress is, however, more complex because it can promote both health (in chronic neurodegenerative diseases) and neuronal death (in acute neural disorders). Thus, each brain pathology requires a specific study of the role played by autophagy. A better understanding of the molecular mechanisms of autophagy and elucidation of the relationship between autophagy and the different cell death pathways in neural disorders will enable autophagy to be manipulated appropriately (stimulation or inhibition) for therapeutic purposes.</p>
<fig id="fig5-1073858411404948" position="float">
<label>Figure 5.</label>
<caption>
<p>Paradoxical roles of autophagy in the nervous system. Basal (or constitutive) autophagy is a physiological process essential for the health of a neuron involved in the turnover of proteins and organelles. A decrease or a failure in basal autophagic activity can cause neurodegeneration. However, its induction can have paradoxical consequences, according to the nature of the stimuli, the intensity of the autophagic activity, and perhaps the context. Autophagy can contribute to cell survival (following deprivation of nutrients or pathogen invasion) or to cell death occurring naturally during development or pathologically (due to cerebral ischemia).</p>
</caption>
<graphic xlink:href="10.1177_1073858411404948-fig5.tif"/>
</fig>
</sec>
</body>
<back>
<ack>
<p>The authors thank all the present and past members of the laboratory who have contributed to the evaluation of the role of autophagy in neuronal cell death.</p>
</ack>
<fn-group>
<fn fn-type="conflict">
<p>The authors declared no potential conflicts of interest with respect to the authorship and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<p>The authors disclosed receipt of the following financial support for the research and/or authorship of this article: The work of our laboratory on autophagy is supported by grant 310030-130769 from the Swiss National Science Foundation and by grants from the Fondation motrice, the fondation Emma Muschamp, and the fondation Thérèse and René Planiol.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Axe</surname><given-names>EL</given-names></name>
<name><surname>Walker</surname><given-names>SA</given-names></name>
<name><surname>Manifava</surname><given-names>M</given-names></name>
<name><surname>Chandra</surname><given-names>P</given-names></name>
<name><surname>Roderick</surname><given-names>HL</given-names></name>
<name><surname>Habermann</surname><given-names>A</given-names></name>
</person-group>, and others. <year>2008</year>. <article-title>Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum</article-title>. <source>J Cell Biol</source> <volume>182</volume>:<fpage>685</fpage>–<lpage>701</lpage>.</citation>
</ref>
<ref id="bibr2-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bialik</surname><given-names>S</given-names></name>
<name><surname>Zalckvar</surname><given-names>E</given-names></name>
<name><surname>Yosef</surname><given-names>N</given-names></name>
<name><surname>Reef</surname><given-names>S</given-names></name>
<name><surname>Ber</surname><given-names>Y</given-names></name>
<name><surname>Rubinstein</surname><given-names>AD</given-names></name>
</person-group>, and others. <year>2010</year>. <article-title>A systems level strategy for analyzing the cell death network: implication in exploring the apoptosis/autophagy connection</article-title>. <source>Cell Death Differ</source> <volume>17</volume>:<fpage>1244</fpage>–<lpage>53</lpage>.</citation>
</ref>
<ref id="bibr3-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bigford</surname><given-names>GE</given-names></name>
<name><surname>Alonso</surname><given-names>OF</given-names></name>
<name><surname>Dietrich</surname><given-names>D</given-names></name>
<name><surname>Keane</surname><given-names>RW</given-names></name>
</person-group>. <year>2009</year>. <article-title>A novel protein complex in membrane rafts linking the NR2B glutamate receptor and autophagy is disrupted following traumatic brain injury</article-title>. <source>J Neurotrauma</source> <volume>26</volume>:<fpage>703</fpage>–<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr4-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Blommaart</surname><given-names>EF</given-names></name>
<name><surname>Krause</surname><given-names>U</given-names></name>
<name><surname>Schellens</surname><given-names>JP</given-names></name>
<name><surname>Vreeling-Sindelarova</surname><given-names>H</given-names></name>
<name><surname>Meijer</surname><given-names>AJ</given-names></name>
</person-group>. <year>1997</year>. <article-title>The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes</article-title>. <source>Eur J Biochem</source> <volume>243</volume>:<fpage>240</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr5-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Borsello</surname><given-names>T</given-names></name>
<name><surname>Croquelois</surname><given-names>K</given-names></name>
<name><surname>Hornung</surname><given-names>JP</given-names></name>
<name><surname>Clarke</surname><given-names>PGH</given-names></name>
</person-group>. <year>2003</year>. <article-title>N-methyl-D-aspartate-triggered neuronal death in organotypic hippocampal cultures is endocytic, autophagic and mediated by the c-Jun N-terminal kinase pathway</article-title>. <source>Eur J Neurosci</source> <volume>18</volume>:<fpage>473</fpage>–<lpage>85</lpage>.</citation>
</ref>
<ref id="bibr6-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bursch</surname><given-names>W</given-names></name>
<name><surname>Hochegger</surname><given-names>K</given-names></name>
<name><surname>Torok</surname><given-names>L</given-names></name>
<name><surname>Marian</surname><given-names>B</given-names></name>
<name><surname>Ellinger</surname><given-names>A</given-names></name>
<name><surname>Hermann</surname><given-names>RS</given-names></name>
</person-group>. <year>2000</year>. <article-title>Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments</article-title>. <source>J Cell Sci</source> <volume>113</volume>:<fpage>1189</fpage>–<lpage>98</lpage>.</citation>
</ref>
<ref id="bibr7-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carloni</surname><given-names>S</given-names></name>
<name><surname>Buonocore</surname><given-names>G</given-names></name>
<name><surname>Balduini</surname><given-names>W</given-names></name>
</person-group>. <year>2008</year>. <article-title>Protective role of autophagy in neonatal hypoxia-ischemia induced brain injury</article-title>. <source>Neurobiol Dis</source> <volume>32</volume>:<fpage>329</fpage>–<lpage>39</lpage>.</citation>
</ref>
<ref id="bibr8-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carrera</surname><given-names>AC</given-names></name>
</person-group>. <year>2004</year>. <article-title>TOR signaling in mammals</article-title>. <source>J Cell Sci</source> <volume>117</volume>: <fpage>4615</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr9-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>Y</given-names></name>
<name><surname>McMillan-Ward</surname><given-names>E</given-names></name>
<name><surname>Kong</surname><given-names>J</given-names></name>
<name><surname>Israels</surname><given-names>SJ</given-names></name>
<name><surname>Gibson</surname><given-names>SB</given-names></name>
</person-group>. <year>2008</year>. <article-title>Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells</article-title>. <source>Cell Death Differ</source> <volume>15</volume>:<fpage>171</fpage>–<lpage>82</lpage>.</citation>
</ref>
<ref id="bibr10-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Clarke</surname><given-names>PGH</given-names></name>
</person-group>. <year>1990</year>. <article-title>Developmental cell death: morphological diversity and multiple mechanisms</article-title>. <source>Anat Embryol</source> <volume>181</volume>:<fpage>195</fpage>–<lpage>213</lpage>.</citation>
</ref>
<ref id="bibr11-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Clarke</surname><given-names>PGH</given-names></name>
<name><surname>Hornung</surname><given-names>JP</given-names></name>
</person-group>. <year>1989</year>. <article-title>Changes in the nuclei of dying neurons as studied with thymidine autoradiography</article-title>. <source>J Comp Neurol</source> <volume>283</volume>:<fpage>438</fpage>–<lpage>49</lpage>.</citation>
</ref>
<ref id="bibr12-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cuervo</surname><given-names>AM</given-names></name>
</person-group>. <year>2004</year>. <article-title>Autophagy: many paths to the same end</article-title>. <source>Mol Cell Biochem</source> <volume>263</volume>:<fpage>55</fpage>–<lpage>72</lpage>.</citation>
</ref>
<ref id="bibr13-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Decker</surname><given-names>RS</given-names></name>
</person-group>. <year>1978</year>. <article-title>Retrograde responses of developing lateral motor column neurons</article-title>. <source>J Comp Neurol</source> <volume>180</volume>:<fpage>635</fpage>–<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr14-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Degterev</surname><given-names>A</given-names></name>
<name><surname>Huang</surname><given-names>Z</given-names></name>
<name><surname>Boyce</surname><given-names>M</given-names></name>
<name><surname>Li</surname><given-names>Y</given-names></name>
<name><surname>Jagtap</surname><given-names>P</given-names></name>
<name><surname>Mizushima</surname><given-names>N</given-names></name>
</person-group>, and others. <year>2005</year>. <article-title>Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury</article-title>. <source>Nat Chem Biol</source> <volume>1</volume>:<fpage>112</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr15-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dehay</surname><given-names>B</given-names></name>
<name><surname>Bove</surname><given-names>J</given-names></name>
<name><surname>Rodriguez-Muela</surname><given-names>N</given-names></name>
<name><surname>Perier</surname><given-names>C</given-names></name>
<name><surname>Recasens</surname><given-names>A</given-names></name>
<name><surname>Boya</surname><given-names>P</given-names></name>
</person-group>, and others. <year>2010</year>. <article-title>Pathogenic lysosomal depletion in Parkinson’s disease</article-title>. <source>J Neurosci</source> <volume>30</volume>:<fpage>12535</fpage>–<lpage>44</lpage>.</citation>
</ref>
<ref id="bibr16-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Erlich</surname><given-names>S</given-names></name>
<name><surname>Shohami</surname><given-names>E</given-names></name>
<name><surname>Pinkas-Kramarski</surname><given-names>R</given-names></name>
</person-group>. <year>2006</year>. <article-title>Neurodegeneration induces upregulation of Beclin 1</article-title>. <source>Autophagy</source> <volume>2</volume>: <fpage>49</fpage>–<lpage>51</lpage>.</citation>
</ref>
<ref id="bibr17-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Geng</surname><given-names>J</given-names></name>
<name><surname>Klionsky</surname><given-names>DJ</given-names></name>
</person-group>. <year>2008</year>. <article-title>The Atg8 and Atg12 ubiquitin-like conjugation systems in macroautophagy. ‘Protein modifications: beyond the usual suspects’ review series</article-title>. <source>EMBO Rep</source> <volume>9</volume>:<fpage>859</fpage>–<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr18-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ginet</surname><given-names>V</given-names></name>
<name><surname>Puyal</surname><given-names>J</given-names></name>
<name><surname>Clarke</surname><given-names>PGH</given-names></name>
<name><surname>Truttmann</surname><given-names>AC</given-names></name>
</person-group>. <year>2009</year>. <article-title>Enhancement of autophagic flux after neonatal cerebral hypoxia-ischemia and its region-specific relationship to apoptotic mechanisms</article-title>. <source>Am J Pathol</source> <volume>175</volume>:<fpage>1962</fpage>–<lpage>74</lpage>.</citation>
</ref>
<ref id="bibr19-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Glick</surname><given-names>D</given-names></name>
<name><surname>Barth</surname><given-names>S</given-names></name>
<name><surname>Macleod</surname><given-names>KF</given-names></name>
</person-group>. <year>2010</year>. <article-title>Autophagy: cellular and molecular mechanisms</article-title>. <source>J Pathol</source> <volume>221</volume>:<fpage>3</fpage>–<lpage>12</lpage>.</citation>
</ref>
<ref id="bibr20-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gonzalez-Martin</surname><given-names>C</given-names></name>
<name><surname>de Diego</surname><given-names>I</given-names></name>
<name><surname>Crespo</surname><given-names>D</given-names></name>
<name><surname>Fairen</surname><given-names>A</given-names></name>
</person-group>. <year>1992</year>. <article-title>Transient c-fos expression accompanies naturally occurring cell death in the developing interhemispheric cortex of the rat</article-title>. <source>Dev Brain Res</source> <volume>68</volume>:<fpage>83</fpage>–<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr21-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Guillon-Munos</surname><given-names>A</given-names></name>
<name><surname>van Bemmelen</surname><given-names>MX</given-names></name>
<name><surname>Clarke</surname><given-names>PGH</given-names></name>
</person-group>. <year>2005</year>. <article-title>Role of phosphoinositide 3-kinase in the autophagic death of serum-deprived PC12 cells</article-title>. <source>Apoptosis</source> <volume>10</volume>:<fpage>1031</fpage>–<lpage>41</lpage>.</citation>
</ref>
<ref id="bibr22-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hailey</surname><given-names>DW</given-names></name>
<name><surname>Rambold</surname><given-names>AS</given-names></name>
<name><surname>Satpute-Krishnan</surname><given-names>P</given-names></name>
<name><surname>Mitra</surname><given-names>K</given-names></name>
<name><surname>Sougrat</surname><given-names>R</given-names></name>
<name><surname>Kim</surname><given-names>PK</given-names></name>
</person-group>, and others. <year>2010</year>. <article-title>Mitochondria supply membranes for autophagosome biogenesis during starvation</article-title>. <source>Cell</source> <volume>141</volume>:<fpage>656</fpage>–<lpage>67</lpage>.</citation>
</ref>
<ref id="bibr23-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hamasaki</surname><given-names>M</given-names></name>
<name><surname>Yoshimori</surname><given-names>T</given-names></name>
</person-group>. <year>2010</year>. <article-title>Where do they come from? Insights into autophagosome formation</article-title>. <source>FEBS Lett</source> <volume>584</volume>: <fpage>1296</fpage>–<lpage>301</lpage>.</citation>
</ref>
<ref id="bibr24-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hara</surname><given-names>T</given-names></name>
<name><surname>Nakamura</surname><given-names>K</given-names></name>
<name><surname>Matsui</surname><given-names>M</given-names></name>
<name><surname>Yamamoto</surname><given-names>A</given-names></name>
<name><surname>Nakahara</surname><given-names>Y</given-names></name>
<name><surname>Suzuki-Migishima</surname><given-names>R</given-names></name>
</person-group>, and others. <year>2006</year>. <article-title>Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice</article-title>. <source>Nature</source> <volume>441</volume>:<fpage>885</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr25-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hara</surname><given-names>T</given-names></name>
<name><surname>Takamura</surname><given-names>A</given-names></name>
<name><surname>Kishi</surname><given-names>C</given-names></name>
<name><surname>Iemura</surname><given-names>S</given-names></name>
<name><surname>Natsume</surname><given-names>T</given-names></name>
<name><surname>Guan</surname><given-names>JL</given-names></name>
</person-group>, and others. <year>2008</year>. <article-title>FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells</article-title>. <source>J Cell Biol</source> <volume>181</volume>:<fpage>497</fpage>–<lpage>510</lpage>.</citation>
</ref>
<ref id="bibr26-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hayashi-Nishino</surname><given-names>M</given-names></name>
<name><surname>Fujita</surname><given-names>N</given-names></name>
<name><surname>Noda</surname><given-names>T</given-names></name>
<name><surname>Yamaguchi</surname><given-names>A</given-names></name>
<name><surname>Yoshimori</surname><given-names>T</given-names></name>
<name><surname>Yamamoto</surname><given-names>A</given-names></name>
</person-group>. <year>2009</year>. <article-title>A subdomain of the endoplasmic reticulum forms a cradle for autophagosome formation</article-title>. <source>Nat Cell Biol</source> <volume>11</volume>:<fpage>1433</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr27-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>He</surname><given-names>C</given-names></name>
<name><surname>Klionsky</surname><given-names>DJ</given-names></name>
</person-group>. <year>2009</year>. <article-title>Regulation mechanisms and signaling pathways of autophagy</article-title>. <source>Annu Rev Genet</source> <volume>43</volume>:<fpage>67</fpage>–<lpage>93</lpage>.</citation>
</ref>
<ref id="bibr28-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hornung</surname><given-names>JP</given-names></name>
<name><surname>Koppel</surname><given-names>H</given-names></name>
<name><surname>Clarke</surname><given-names>PGH</given-names></name>
</person-group>. <year>1989</year>. <article-title>Endocytosis and autophagy in dying neurons: an ultrastructural study in chick embryos</article-title>. <source>J Comp Neurol</source> <volume>283</volume>:<fpage>425</fpage>–<lpage>37</lpage>.</citation>
</ref>
<ref id="bibr29-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hosokawa</surname><given-names>N</given-names></name>
<name><surname>Hara</surname><given-names>T</given-names></name>
<name><surname>Kaizuka</surname><given-names>T</given-names></name>
<name><surname>Kishi</surname><given-names>C</given-names></name>
<name><surname>Takamura</surname><given-names>A</given-names></name>
<name><surname>Miura</surname><given-names>Y</given-names></name>
</person-group>, and others. <year>2009</year>. <article-title>Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy</article-title>. <source>Mol Biol Cell</source> <volume>20</volume>:<fpage>1981</fpage>–<lpage>91</lpage>.</citation>
</ref>
<ref id="bibr30-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Itakura</surname><given-names>E</given-names></name>
<name><surname>Kishi</surname><given-names>C</given-names></name>
<name><surname>Inoue</surname><given-names>K</given-names></name>
<name><surname>Mizushima</surname><given-names>N</given-names></name>
</person-group>. <year>2008</year>. <article-title>Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG</article-title>. <source>Mol Biol Cell</source> <volume>19</volume>: <fpage>5360</fpage>–<lpage>72</lpage>.</citation>
</ref>
<ref id="bibr31-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jung</surname><given-names>CH</given-names></name>
<name><surname>Jun</surname><given-names>CB</given-names></name>
<name><surname>Ro</surname><given-names>SH</given-names></name>
<name><surname>Kim</surname><given-names>YM</given-names></name>
<name><surname>Otto</surname><given-names>NM</given-names></name>
<name><surname>Cao</surname><given-names>J</given-names></name>
</person-group>, and others. <year>2009</year>. <article-title>ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery</article-title>. <source>Mol Biol Cell</source> <volume>20</volume>:<fpage>1992</fpage>–<lpage>2003</lpage>.</citation>
</ref>
<ref id="bibr32-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kabeya</surname><given-names>Y</given-names></name>
<name><surname>Mizushima</surname><given-names>N</given-names></name>
<name><surname>Ueno</surname><given-names>T</given-names></name>
<name><surname>Yamamoto</surname><given-names>A</given-names></name>
<name><surname>Kirisako</surname><given-names>T</given-names></name>
<name><surname>Noda</surname><given-names>T</given-names></name>
</person-group>, and others. <year>2000</year>. <article-title>LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing</article-title>. <source>EMBO J</source> <volume>19</volume>:<fpage>5720</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr33-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kandouz</surname><given-names>M</given-names></name>
<name><surname>Haidara</surname><given-names>K</given-names></name>
<name><surname>Zhao</surname><given-names>J</given-names></name>
<name><surname>Brisson</surname><given-names>ML</given-names></name>
<name><surname>Batist</surname><given-names>G</given-names></name>
</person-group>. <year>2010</year>. <article-title>The EphB2 tumor suppressor induces autophagic cell death via concomitant activation of the ERK1/2 and PI3K pathways</article-title>. <source>Cell Cycle</source> <volume>9</volume>:<fpage>398</fpage>–<lpage>407</lpage>.</citation>
</ref>
<ref id="bibr34-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kanno</surname><given-names>H</given-names></name>
<name><surname>Ozawa</surname><given-names>H</given-names></name>
<name><surname>Sekiguchi</surname><given-names>A</given-names></name>
<name><surname>Itoi</surname><given-names>E</given-names></name>
</person-group>. <year>2009</year>. <article-title>Spinal cord injury induces upregulation of Beclin 1 and promotes autophagic cell death</article-title>. <source>Neurobiol Dis</source> <volume>33</volume>:<fpage>143</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr35-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Klionsky</surname><given-names>DJ</given-names></name>
<name><surname>Abeliovich</surname><given-names>H</given-names></name>
<name><surname>Agostinis</surname><given-names>P</given-names></name>
<name><surname>Agrawal</surname><given-names>DK</given-names></name>
<name><surname>Aliev</surname><given-names>G</given-names></name>
<name><surname>Askew</surname><given-names>DS</given-names></name>
</person-group>, and others. <year>2008</year>. <article-title>Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes</article-title>. <source>Autophagy</source> <volume>4</volume>:<fpage>151</fpage>–<lpage>75</lpage>.</citation>
</ref>
<ref id="bibr36-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Koike</surname><given-names>M</given-names></name>
<name><surname>Shibata</surname><given-names>M</given-names></name>
<name><surname>Tadakoshi</surname><given-names>M</given-names></name>
<name><surname>Gotoh</surname><given-names>K</given-names></name>
<name><surname>Komatsu</surname><given-names>M</given-names></name>
<name><surname>Waguri</surname><given-names>S</given-names></name>
</person-group>, and others. <year>2008</year>. <article-title>Inhibition of autophagy prevents hippocampal pyramidal neuron death after hypoxic-ischemic injury</article-title>. <source>Am J Pathol</source> <volume>172</volume>:<fpage>454</fpage>–<lpage>69</lpage>.</citation>
</ref>
<ref id="bibr37-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Komatsu</surname><given-names>M</given-names></name>
<name><surname>Waguri</surname><given-names>S</given-names></name>
<name><surname>Chiba</surname><given-names>T</given-names></name>
<name><surname>Murata</surname><given-names>S</given-names></name>
<name><surname>Iwata</surname><given-names>J</given-names></name>
<name><surname>Tanida</surname><given-names>I</given-names></name>
</person-group>, and others. <year>2006</year>. <article-title>Loss of autophagy in the central nervous system causes neurodegeneration in mice</article-title>. <source>Nature</source> <volume>441</volume>:<fpage>880</fpage>–<lpage>4</lpage>.</citation>
</ref>
<ref id="bibr38-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Komatsu</surname><given-names>M</given-names></name>
<name><surname>Waguri</surname><given-names>S</given-names></name>
<name><surname>Ueno</surname><given-names>T</given-names></name>
<name><surname>Iwata</surname><given-names>J</given-names></name>
<name><surname>Murata</surname><given-names>S</given-names></name>
<name><surname>Tanida</surname><given-names>I</given-names></name>
</person-group>, and others. <year>2005</year>. <article-title>Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice</article-title>. <source>J Cell Biol</source> <volume>169</volume>:<fpage>425</fpage>–<lpage>34</lpage>.</citation>
</ref>
<ref id="bibr39-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Komatsu</surname><given-names>M</given-names></name>
<name><surname>Wang</surname><given-names>QJ</given-names></name>
<name><surname>Holstein</surname><given-names>GR</given-names></name>
<name><surname>Friedrich</surname><given-names>VL</given-names><suffix>Jr</suffix></name>
<name><surname>Iwata</surname><given-names>J</given-names></name>
<name><surname>Kominami</surname><given-names>E</given-names></name>
</person-group>, and others. <year>2007</year>. <article-title>Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>104</volume>:<fpage>14489</fpage>–<lpage>94</lpage>.</citation>
</ref>
<ref id="bibr40-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kroemer</surname><given-names>G</given-names></name>
<name><surname>Levine</surname><given-names>B</given-names></name>
</person-group>. <year>2008</year>. <article-title>Autophagic cell death: the story of a misnomer</article-title>. <source>Nat Rev Mol Cell Biol</source> <volume>9</volume>:<fpage>1004</fpage>–<lpage>10</lpage>.</citation>
</ref>
<ref id="bibr41-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kuma</surname><given-names>A</given-names></name>
<name><surname>Hatano</surname><given-names>M</given-names></name>
<name><surname>Matsui</surname><given-names>M</given-names></name>
<name><surname>Yamamoto</surname><given-names>A</given-names></name>
<name><surname>Nakaya</surname><given-names>H</given-names></name>
<name><surname>Yoshimori</surname><given-names>T</given-names></name>
</person-group>, and others. <year>2004</year>. <article-title>The role of autophagy during the early neonatal starvation period</article-title>. <source>Nature</source> <volume>432</volume>:<fpage>1032</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr42-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lamborghini</surname><given-names>JE</given-names></name>
</person-group>. <year>1987</year>. <article-title>Disappearance of Rohon-Beard neurons from the spinal cord of larval Xenopus laevis</article-title>. <source>J Comp Neurol</source> <volume>264</volume>:<fpage>47</fpage>–<lpage>55</lpage>.</citation>
</ref>
<ref id="bibr43-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>JH</given-names></name>
<name><surname>Yu</surname><given-names>WH</given-names></name>
<name><surname>Kumar</surname><given-names>A</given-names></name>
<name><surname>Lee</surname><given-names>S</given-names></name>
<name><surname>Mohan</surname><given-names>PS</given-names></name>
<name><surname>Peterhoff</surname><given-names>CM</given-names></name>
</person-group>, and others. <year>2010</year>. <article-title>Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations</article-title>. <source>Cell</source> <volume>141</volume>:<fpage>1146</fpage>–<lpage>58</lpage>.</citation>
</ref>
<ref id="bibr44-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Legakis</surname><given-names>JE</given-names></name>
<name><surname>Yen</surname><given-names>WL</given-names></name>
<name><surname>Klionsky</surname><given-names>DJ</given-names></name>
</person-group>. <year>2007</year>. <article-title>A cycling protein complex required for selective autophagy</article-title>. <source>Autophagy</source> <volume>3</volume>: <fpage>422</fpage>–<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr45-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liang</surname><given-names>C</given-names></name>
<name><surname>Sir</surname><given-names>D</given-names></name>
<name><surname>Lee</surname><given-names>S</given-names></name>
<name><surname>Ou</surname><given-names>JH</given-names></name>
<name><surname>Jung</surname><given-names>JU</given-names></name>
</person-group>. <year>2008</year>. <article-title>Beyond autophagy: the role of UVRAG in membrane trafficking</article-title>. <source>Autophagy</source> <volume>4</volume>:<fpage>817</fpage>–<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr46-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Longatti</surname><given-names>A</given-names></name>
<name><surname>Tooze</surname><given-names>SA</given-names></name>
</person-group>. <year>2009</year>. <article-title>Vesicular trafficking and autophagosome formation</article-title>. <source>Cell Death Differ</source> <volume>16</volume>:<fpage>956</fpage>–<lpage>65</lpage>.</citation>
</ref>
<ref id="bibr47-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Luo</surname><given-names>S</given-names></name>
<name><surname>Rubinsztein</surname><given-names>DC</given-names></name>
</person-group>. <year>2010</year>. <article-title>Apoptosis blocks Beclin 1–dependent autophagosome synthesis: an effect rescued by Bcl-xL</article-title>. <source>Cell Death Differ</source> <volume>17</volume>:<fpage>268</fpage>–<lpage>77</lpage>.</citation>
</ref>
<ref id="bibr48-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Maiuri</surname><given-names>MC</given-names></name>
<name><surname>Le Toumelin</surname><given-names>G</given-names></name>
<name><surname>Criollo</surname><given-names>A</given-names></name>
<name><surname>Rain</surname><given-names>JC</given-names></name>
<name><surname>Gautier</surname><given-names>F</given-names></name>
<name><surname>Juin</surname><given-names>P</given-names></name>
</person-group>, and others. <year>2007</year>. <article-title>Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1</article-title>. <source>EMBO J</source> <volume>26</volume>:<fpage>2527</fpage>–<lpage>39</lpage>.</citation>
</ref>
<ref id="bibr49-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mehrpour</surname><given-names>M</given-names></name>
<name><surname>Esclatine</surname><given-names>A</given-names></name>
<name><surname>Beau</surname><given-names>I</given-names></name>
<name><surname>Codogno</surname><given-names>P</given-names></name>
</person-group>. <year>2010</year>. <article-title>Overview of macroautophagy regulation in mammalian cells</article-title>. <source>Cell Res</source> <volume>20</volume>:<fpage>748</fpage>–<lpage>62</lpage>.</citation>
</ref>
<ref id="bibr50-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mizushima</surname><given-names>N</given-names></name>
<name><surname>Kuma</surname><given-names>A</given-names></name>
<name><surname>Kobayashi</surname><given-names>Y</given-names></name>
<name><surname>Yamamoto</surname><given-names>A</given-names></name>
<name><surname>Matsubae</surname><given-names>M</given-names></name>
<name><surname>Takao</surname><given-names>T</given-names></name>
</person-group>, and others. <year>2003</year>. <article-title>Mouse Apg16L, a novel WD-repeat protein, targets to the autophagic isolation membrane with the Apg12-Apg5 conjugate</article-title>. <source>J Cell Sci</source> <volume>116</volume>:<fpage>1679</fpage>–<lpage>88</lpage>.</citation>
</ref>
<ref id="bibr51-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nakatogawa</surname><given-names>H</given-names></name>
<name><surname>Ichimura</surname><given-names>Y</given-names></name>
<name><surname>Ohsumi</surname><given-names>Y</given-names></name>
</person-group>. <year>2007</year>. <article-title>Atg8, a ubiquitin-like protein required for autophagosome formation, mediates membrane tethering and hemifusion</article-title>. <source>Cell</source> <volume>130</volume>:<fpage>165</fpage>–<lpage>78</lpage>.</citation>
</ref>
<ref id="bibr52-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Narendra</surname><given-names>D</given-names></name>
<name><surname>Tanaka</surname><given-names>A</given-names></name>
<name><surname>Suen</surname><given-names>DF</given-names></name>
<name><surname>Youle</surname><given-names>RJ</given-names></name>
</person-group>. <year>2008</year>. <article-title>Parkin is recruited selectively to impaired mitochondria and promotes their autophagy</article-title>. <source>J Cell Biol</source> <volume>183</volume>:<fpage>795</fpage>–<lpage>803</lpage>.</citation>
</ref>
<ref id="bibr53-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nishiyama</surname><given-names>J</given-names></name>
<name><surname>Matsuda</surname><given-names>K</given-names></name>
<name><surname>Kakegawa</surname><given-names>W</given-names></name>
<name><surname>Yamada</surname><given-names>N</given-names></name>
<name><surname>Motohashi</surname><given-names>J</given-names></name>
<name><surname>Mizushima</surname><given-names>N</given-names></name>
</person-group>, and others. <year>2010</year>. <article-title>Reevaluation of neurodegeneration in lurcher mice: constitutive ion fluxes cause cell death with, not by, autophagy</article-title>. <source>J Neurosci</source> <volume>30</volume>:<fpage>2177</fpage>–<lpage>87</lpage>.</citation>
</ref>
<ref id="bibr54-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nishiyama</surname><given-names>J</given-names></name>
<name><surname>Miura</surname><given-names>E</given-names></name>
<name><surname>Mizushima</surname><given-names>N</given-names></name>
<name><surname>Watanabe</surname><given-names>M</given-names></name>
<name><surname>Yuzaki</surname><given-names>M</given-names></name>
</person-group>. <year>2007</year>. <article-title>Aberrant membranes and double-membrane structures accumulate in the axons of Atg5-null Purkinje cells before neuronal death</article-title>. <source>Autophagy</source> <volume>3</volume>:<fpage>591</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr55-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nitatori</surname><given-names>T</given-names></name>
<name><surname>Sato</surname><given-names>N</given-names></name>
<name><surname>Kominami</surname><given-names>E</given-names></name>
<name><surname>Uchiyama</surname><given-names>Y</given-names></name>
</person-group>. <year>1996</year>. <article-title>Participation of cathepsins B, H, and L in perikaryal condensation of CA1 pyramidal neurons undergoing apoptosis after brief ischemia</article-title>. <source>Adv Exp Med Biol</source> <volume>389</volume>:<fpage>177</fpage>–<lpage>85</lpage>.</citation>
</ref>
<ref id="bibr56-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nitatori</surname><given-names>T</given-names></name>
<name><surname>Sato</surname><given-names>N</given-names></name>
<name><surname>Waguri</surname><given-names>S</given-names></name>
<name><surname>Karasawa</surname><given-names>Y</given-names></name>
<name><surname>Araki</surname><given-names>H</given-names></name>
<name><surname>Shibanai</surname><given-names>K</given-names></name>
</person-group>, and others. <year>1995</year>. <article-title>Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis</article-title>. <source>J Neurosci</source> <volume>15</volume>:<fpage>1001</fpage>–<lpage>11</lpage>.</citation>
</ref>
<ref id="bibr57-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nixon</surname><given-names>RA</given-names></name>
</person-group>. <year>2007</year>. <article-title>Autophagy, amyloidogenesis and Alzheimer disease</article-title>. <source>J Cell Sci</source> <volume>120</volume>:<fpage>4081</fpage>–<lpage>91</lpage>.</citation>
</ref>
<ref id="bibr58-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nixon</surname><given-names>RA</given-names></name>
<name><surname>Wegiel</surname><given-names>J</given-names></name>
<name><surname>Kumar</surname><given-names>A</given-names></name>
<name><surname>Yu</surname><given-names>WH</given-names></name>
<name><surname>Peterhoff</surname><given-names>C</given-names></name>
<name><surname>Cataldo</surname><given-names>A</given-names></name>
</person-group>, and others. <year>2005</year>. <article-title>Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study</article-title>. <source>J Neuropathol Exp Neurol</source> <volume>64</volume>:<fpage>113</fpage>–<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr59-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pandey</surname><given-names>UB</given-names></name>
<name><surname>Nie</surname><given-names>Z</given-names></name>
<name><surname>Batlevi</surname><given-names>Y</given-names></name>
<name><surname>McCray</surname><given-names>BA</given-names></name>
<name><surname>Ritson</surname><given-names>GP</given-names></name>
<name><surname>Nedelsky</surname><given-names>NB</given-names></name>
</person-group>, and others. <year>2007</year>. <article-title>HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS</article-title>. <source>Nature</source> <volume>447</volume>:<fpage>859</fpage>–<lpage>63</lpage>.</citation>
</ref>
<ref id="bibr60-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pankiv</surname><given-names>S</given-names></name>
<name><surname>Clausen</surname><given-names>TH</given-names></name>
<name><surname>Lamark</surname><given-names>T</given-names></name>
<name><surname>Brech</surname><given-names>A</given-names></name>
<name><surname>Bruun</surname><given-names>JA</given-names></name>
<name><surname>Outzen</surname><given-names>H</given-names></name>
</person-group>, and others. <year>2007</year>. <article-title>p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy</article-title>. <source>J Biol Chem</source> <volume>282</volume>:<fpage>24131</fpage>–<lpage>45</lpage>.</citation>
</ref>
<ref id="bibr61-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pattingre</surname><given-names>S</given-names></name>
<name><surname>Espert</surname><given-names>L</given-names></name>
<name><surname>Biard-Piechaczyk</surname><given-names>M</given-names></name>
<name><surname>Codogno</surname><given-names>P</given-names></name>
</person-group>. <year>2008</year>. <article-title>Regulation of macroautophagy by mTOR and Beclin 1 complexes</article-title>. <source>Biochimie</source> <volume>90</volume>:<fpage>313</fpage>–<lpage>23</lpage>.</citation>
</ref>
<ref id="bibr62-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Puyal</surname><given-names>J</given-names></name>
<name><surname>Clarke</surname><given-names>PGH</given-names></name>
</person-group>. <year>2009</year>. <article-title>Targeting autophagy to prevent neonatal stroke damage</article-title>. <source>Autophagy</source> <volume>5</volume>:<fpage>1060</fpage>–<lpage>1</lpage>.</citation>
</ref>
<ref id="bibr63-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Puyal</surname><given-names>J</given-names></name>
<name><surname>Vaslin</surname><given-names>A</given-names></name>
<name><surname>Mottier</surname><given-names>V</given-names></name>
<name><surname>Clarke</surname><given-names>PGH</given-names></name>
</person-group>. <year>2009</year>. <article-title>Postischemic treatment of neonatal cerebral ischemia should target autophagy</article-title>. <source>Ann Neurol</source> <volume>66</volume>:<fpage>378</fpage>–<lpage>89</lpage>.</citation>
</ref>
<ref id="bibr64-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ravikumar</surname><given-names>B</given-names></name>
<name><surname>Duden</surname><given-names>R</given-names></name>
<name><surname>Rubinsztein</surname><given-names>DC</given-names></name>
</person-group>. <year>2002</year>. <article-title>Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy</article-title>. <source>Hum Mol Genet</source> <volume>11</volume>:<fpage>1107</fpage>–<lpage>17</lpage>.</citation>
</ref>
<ref id="bibr65-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ravikumar</surname><given-names>B</given-names></name>
<name><surname>Moreau</surname><given-names>K</given-names></name>
<name><surname>Jahreiss</surname><given-names>L</given-names></name>
<name><surname>Puri</surname><given-names>C</given-names></name>
<name><surname>Rubinsztein</surname><given-names>DC</given-names></name>
</person-group>. <year>2010</year>. <article-title>Plasma membrane contributes to the formation of pre-autophagosomal structures</article-title>. <source>Nat Cell Biol</source> <volume>12</volume>:<fpage>747</fpage>–<lpage>57</lpage>.</citation>
</ref>
<ref id="bibr66-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ravikumar</surname><given-names>B</given-names></name>
<name><surname>Vacher</surname><given-names>C</given-names></name>
<name><surname>Berger</surname><given-names>Z</given-names></name>
<name><surname>Davies</surname><given-names>JE</given-names></name>
<name><surname>Luo</surname><given-names>S</given-names></name>
<name><surname>Oroz</surname><given-names>LG</given-names></name>
</person-group>, and others. <year>2004</year>. <article-title>Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease</article-title>. <source>Nat Genet</source> <volume>36</volume>:<fpage>585</fpage>–<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr67-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Reggiori</surname><given-names>F</given-names></name>
<name><surname>Tucker</surname><given-names>KA</given-names></name>
<name><surname>Stromhaug</surname><given-names>PE</given-names></name>
<name><surname>Klionsky</surname><given-names>DJ</given-names></name>
</person-group>. <year>2004</year>. <article-title>The Atg1-Atg13 complex regulates Atg9 and Atg23 retrieval transport from the pre-autophagosomal structure</article-title>. <source>Dev Cell</source> <volume>6</volume>:<fpage>79</fpage>–<lpage>90</lpage>.</citation>
</ref>
<ref id="bibr68-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rubinsztein</surname><given-names>DC</given-names></name>
<name><surname>Difiglia</surname><given-names>M</given-names></name>
<name><surname>Heintz</surname><given-names>N</given-names></name>
<name><surname>Nixon</surname><given-names>RA</given-names></name>
<name><surname>Qin</surname><given-names>ZH</given-names></name>
<name><surname>Ravikumar</surname><given-names>B</given-names></name>
</person-group>, and others. <year>2005</year>. <article-title>Autophagy and its possible roles in nervous system diseases, damage and repair</article-title>. <source>Autophagy</source> <volume>1</volume>:<fpage>11</fpage>–<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr69-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sandvig</surname><given-names>K</given-names></name>
<name><surname>van Deurs</surname><given-names>B</given-names></name>
</person-group>. <year>1992</year>. <article-title>Toxin-induced cell lysis: protection by 3-methyladenine and cycloheximide</article-title>. <source>Exp Cell Res</source> <volume>200</volume>:<fpage>253</fpage>–<lpage>62</lpage>.</citation>
</ref>
<ref id="bibr70-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sarkar</surname><given-names>S</given-names></name>
<name><surname>Ravikumar</surname><given-names>B</given-names></name>
<name><surname>Floto</surname><given-names>RA</given-names></name>
<name><surname>Rubinsztein</surname><given-names>DC</given-names></name>
</person-group>. <year>2009</year>. <article-title>Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies</article-title>. <source>Cell Death Differ</source> <volume>16</volume>:<fpage>46</fpage>–<lpage>56</lpage>.</citation>
</ref>
<ref id="bibr71-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schweichel</surname><given-names>JU</given-names></name>
<name><surname>Merker</surname><given-names>HJ</given-names></name>
</person-group>. <year>1973</year>. <article-title>The morphology of various types of cell death in prenatal tissues</article-title>. <source>Teratology</source> <volume>7</volume>:<fpage>253</fpage>–<lpage>66</lpage>.</citation>
</ref>
<ref id="bibr72-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Selimi</surname><given-names>F</given-names></name>
<name><surname>Lohof</surname><given-names>AM</given-names></name>
<name><surname>Heitz</surname><given-names>S</given-names></name>
<name><surname>Lalouette</surname><given-names>A</given-names></name>
<name><surname>Jarvis</surname><given-names>CI</given-names></name>
<name><surname>Bailly</surname><given-names>Y</given-names></name>
</person-group>, and others. <year>2003</year>. <article-title>Lurcher GRID2-induced death and depolarization can be dissociated in cerebellar Purkinje cells</article-title>. <source>Neuron</source> <volume>37</volume>:<fpage>813</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr73-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Seyfried</surname><given-names>D</given-names></name>
<name><surname>Han</surname><given-names>Y</given-names></name>
<name><surname>Zheng</surname><given-names>Z</given-names></name>
<name><surname>Day</surname><given-names>N</given-names></name>
<name><surname>Moin</surname><given-names>K</given-names></name>
<name><surname>Rempel</surname><given-names>S</given-names></name>
</person-group>, and others. <year>1997</year>. <article-title>Cathepsin B and middle cerebral artery occlusion in the rat</article-title>. <source>J Neurosurg</source> <volume>87</volume>:<fpage>716</fpage>–<lpage>23</lpage>.</citation>
</ref>
<ref id="bibr74-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shacka</surname><given-names>JJ</given-names></name>
<name><surname>Lu</surname><given-names>J</given-names></name>
<name><surname>Xie</surname><given-names>ZL</given-names></name>
<name><surname>Uchiyama</surname><given-names>Y</given-names></name>
<name><surname>Roth</surname><given-names>KA</given-names></name>
<name><surname>Zhang</surname><given-names>J</given-names></name>
</person-group>. <year>2007</year>. <article-title>Kainic acid induces early and transient autophagic stress in mouse hippocampus</article-title>. <source>Neurosci Lett</source> <volume>414</volume>:<fpage>57</fpage>–<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr75-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shimizu</surname><given-names>S</given-names></name>
<name><surname>Kanaseki</surname><given-names>T</given-names></name>
<name><surname>Mizushima</surname><given-names>N</given-names></name>
<name><surname>Mizuta</surname><given-names>T</given-names></name>
<name><surname>Arakawa-Kobayashi</surname><given-names>S</given-names></name>
<name><surname>Thompson</surname><given-names>CB</given-names></name>
</person-group>, and others. <year>2004</year>. <article-title>Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes</article-title>. <source>Nat Cell Biol</source> <volume>6</volume>: <fpage>1221</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr76-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sun</surname><given-names>Q</given-names></name>
<name><surname>Fan</surname><given-names>W</given-names></name>
<name><surname>Chen</surname><given-names>K</given-names></name>
<name><surname>Ding</surname><given-names>X</given-names></name>
<name><surname>Chen</surname><given-names>S</given-names></name>
<name><surname>Zhong</surname><given-names>Q</given-names></name>
</person-group>. <year>2008</year>. <article-title>Identification of Barkor as a mammalian autophagy-specific factor for Beclin 1 and class III phosphatidylinositol 3-kinase</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>105</volume>:<fpage>19211</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr77-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Swiech</surname><given-names>L</given-names></name>
<name><surname>Perycz</surname><given-names>M</given-names></name>
<name><surname>Malik</surname><given-names>A</given-names></name>
<name><surname>Jaworski</surname><given-names>J</given-names></name>
</person-group>. <year>2008</year>. <article-title>Role of mTOR in physiology and pathology of the nervous system</article-title>. <source>Biochim Biophys Acta</source> <volume>1784</volume>:<fpage>116</fpage>–<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr78-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Takahashi</surname><given-names>Y</given-names></name>
<name><surname>Meyerkord</surname><given-names>CL</given-names></name>
<name><surname>Wang</surname><given-names>HG</given-names></name>
</person-group>. <year>2009</year>. <article-title>Bif-1/endophilin B1: a candidate for crescent driving force in autophagy</article-title>. <source>Cell Death Differ</source> <volume>16</volume>:<fpage>947</fpage>–<lpage>55</lpage>.</citation>
</ref>
<ref id="bibr79-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Uchiyama</surname><given-names>Y</given-names></name>
<name><surname>Koike</surname><given-names>M</given-names></name>
<name><surname>Shibata</surname><given-names>M</given-names></name>
<name><surname>Sasaki</surname><given-names>M</given-names></name>
</person-group>. <year>2009</year>. <article-title>Autophagic neuron death</article-title>. <source>Methods Enzymol</source> <volume>453</volume>:<fpage>33</fpage>–<lpage>51</lpage>.</citation>
</ref>
<ref id="bibr80-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wan</surname><given-names>G</given-names></name>
<name><surname>Zhaorigetu</surname><given-names>S</given-names></name>
<name><surname>Liu</surname><given-names>Z</given-names></name>
<name><surname>Kaini</surname><given-names>R</given-names></name>
<name><surname>Jiang</surname><given-names>Z</given-names></name>
<name><surname>Hu</surname><given-names>CA</given-names></name>
</person-group>. <year>2008</year>. <article-title>Apolipoprotein L1, a novel Bcl-2 homology domain 3–only lipid-binding protein, induces autophagic cell death</article-title>. <source>J Biol Chem</source> <volume>283</volume>:<fpage>21540</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr81-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>CW</given-names></name>
<name><surname>Klionsky</surname><given-names>DJ</given-names></name>
</person-group>. <year>2003</year>. <article-title>The molecular mechanism of autophagy</article-title>. <source>Mol Med</source> <volume>9</volume>:<fpage>65</fpage>–<lpage>76</lpage>.</citation>
</ref>
<ref id="bibr82-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>Y</given-names></name>
<name><surname>Dong</surname><given-names>XX</given-names></name>
<name><surname>Cao</surname><given-names>Y</given-names></name>
<name><surname>Liang</surname><given-names>ZQ</given-names></name>
<name><surname>Han</surname><given-names>R</given-names></name>
<name><surname>Wu</surname><given-names>JC</given-names></name>
</person-group>, and others. <year>2009</year>. <article-title>p53 induction contributes to excitotoxic neuronal death in rat striatum through apoptotic and autophagic mechanisms</article-title>. <source>Eur J Neurosci</source> <volume>30</volume>:<fpage>2258</fpage>–<lpage>70</lpage>.</citation>
</ref>
<ref id="bibr83-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>Y</given-names></name>
<name><surname>Han</surname><given-names>R</given-names></name>
<name><surname>Liang</surname><given-names>ZQ</given-names></name>
<name><surname>Wu</surname><given-names>JC</given-names></name>
<name><surname>Zhang</surname><given-names>XD</given-names></name>
<name><surname>Gu</surname><given-names>ZL</given-names></name>
</person-group>, and others. <year>2008</year>. <article-title>An autophagic mechanism is involved in apoptotic death of rat striatal neurons induced by the non-N-methyl-D-aspartate receptor agonist kainic acid</article-title>. <source>Autophagy</source> <volume>4</volume>:<fpage>214</fpage>–<lpage>26</lpage>.</citation>
</ref>
<ref id="bibr84-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>ZV</given-names></name>
<name><surname>Rothermel</surname><given-names>BA</given-names></name>
<name><surname>Hill</surname><given-names>JA</given-names></name>
</person-group>. <year>2010</year>. <article-title>Autophagy in hypertensive heart disease</article-title>. <source>J Biol Chem</source> <volume>285</volume>:<fpage>8509</fpage>–<lpage>14</lpage>.</citation>
</ref>
<ref id="bibr85-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Webb</surname><given-names>JL</given-names></name>
<name><surname>Ravikumar</surname><given-names>B</given-names></name>
<name><surname>Atkins</surname><given-names>J</given-names></name>
<name><surname>Skepper</surname><given-names>JN</given-names></name>
<name><surname>Rubinsztein</surname><given-names>DC</given-names></name>
</person-group>. <year>2003</year>. <article-title>Alpha-Synuclein is degraded by both autophagy and the proteasome</article-title>. <source>J Biol Chem</source> <volume>278</volume>:<fpage>25009</fpage>–<lpage>13</lpage>.</citation>
</ref>
<ref id="bibr86-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Webb</surname><given-names>JL</given-names></name>
<name><surname>Ravikumar</surname><given-names>B</given-names></name>
<name><surname>Rubinsztein</surname><given-names>DC</given-names></name>
</person-group>. <year>2004</year>. <article-title>Microtubule disruption inhibits autophagosome-lysosome fusion: implications for studying the roles of aggresomes in polyglutamine diseases</article-title>. <source>Int J Biochem Cell Biol</source> <volume>36</volume>:<fpage>2541</fpage>–<lpage>50</lpage>.</citation>
</ref>
<ref id="bibr87-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Webber</surname><given-names>JL</given-names></name>
<name><surname>Young</surname><given-names>AR</given-names></name>
<name><surname>Tooze</surname><given-names>SA</given-names></name>
</person-group>. <year>2007</year>. <article-title>Atg9 trafficking in mammalian cells</article-title>. <source>Autophagy</source> <volume>3</volume>:<fpage>54</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr88-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wen</surname><given-names>YD</given-names></name>
<name><surname>Sheng</surname><given-names>R</given-names></name>
<name><surname>Zhang</surname><given-names>LS</given-names></name>
<name><surname>Han</surname><given-names>R</given-names></name>
<name><surname>Zhang</surname><given-names>X</given-names></name>
<name><surname>Zhang</surname><given-names>XD</given-names></name>
</person-group>, and others. <year>2008</year>. <article-title>Neuronal injury in rat model of permanent focal cerebral ischemia is associated with activation of autophagic and lysosomal pathways</article-title>. <source>Autophagy</source> <volume>4</volume>:<fpage>762</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr89-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wu</surname><given-names>YT</given-names></name>
<name><surname>Tan</surname><given-names>HL</given-names></name>
<name><surname>Shui</surname><given-names>G</given-names></name>
<name><surname>Bauvy</surname><given-names>C</given-names></name>
<name><surname>Huang</surname><given-names>Q</given-names></name>
<name><surname>Wenk</surname><given-names>MR</given-names></name>
</person-group>, and others. <year>2010</year>. <article-title>Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase</article-title>. <source>J Biol Chem</source> <volume>285</volume>:<fpage>10850</fpage>–<lpage>61</lpage>.</citation>
</ref>
<ref id="bibr90-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Xue</surname><given-names>L</given-names></name>
<name><surname>Fletcher</surname><given-names>GC</given-names></name>
<name><surname>Tolkovsky</surname><given-names>AM</given-names></name>
</person-group>. <year>1999</year>. <article-title>Autophagy is activated by apoptotic signalling in sympathetic neurons: an alternative mechanism of death execution</article-title>. <source>Mol Cell Neurosci</source> <volume>14</volume>:<fpage>180</fpage>–<lpage>98</lpage>.</citation>
</ref>
<ref id="bibr91-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yang</surname><given-names>DS</given-names></name>
<name><surname>Stavrides</surname><given-names>P</given-names></name>
<name><surname>Mohan</surname><given-names>PS</given-names></name>
<name><surname>Kaushik</surname><given-names>S</given-names></name>
<name><surname>Kumar</surname><given-names>A</given-names></name>
<name><surname>Ohno</surname><given-names>M</given-names></name>
</person-group>, and others. <year>2011</year>. <article-title>Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer’s disease ameliorates amyloid pathologies and memory deficits</article-title>. <source>Brain</source> <volume>134</volume>:<fpage>258</fpage>–<lpage>77</lpage>.</citation>
</ref>
<ref id="bibr92-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yang</surname><given-names>Z</given-names></name>
<name><surname>Klionsky</surname><given-names>DJ</given-names></name>
</person-group>. <year>2010</year>. <article-title>Mammalian autophagy: core molecular machinery and signaling regulation</article-title>. <source>Curr Opin Cell Biol</source> <volume>22</volume>:<fpage>124</fpage>–<lpage>31</lpage>.</citation>
</ref>
<ref id="bibr93-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yousefi</surname><given-names>S</given-names></name>
<name><surname>Simon</surname><given-names>HU</given-names></name>
</person-group>. <year>2009</year>. <article-title>Autophagy in cancer and chemotherapy</article-title>. <source>Results Probl Cell Differ</source> <volume>49</volume>:<fpage>183</fpage>–<lpage>90</lpage>.</citation>
</ref>
<ref id="bibr94-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yu</surname><given-names>L</given-names></name>
<name><surname>Alva</surname><given-names>A</given-names></name>
<name><surname>Su</surname><given-names>H</given-names></name>
<name><surname>Dutt</surname><given-names>P</given-names></name>
<name><surname>Freundt</surname><given-names>E</given-names></name>
<name><surname>Welsh</surname><given-names>S</given-names></name>
</person-group>, and others. <year>2004</year>. <article-title>Regulation of an ATG7–Beclin 1 program of autophagic cell death by caspase-8</article-title>. <source>Science</source> <volume>304</volume>:<fpage>1500</fpage>–<lpage>2</lpage>.</citation>
</ref>
<ref id="bibr95-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yu</surname><given-names>L</given-names></name>
<name><surname>Wan</surname><given-names>F</given-names></name>
<name><surname>Dutta</surname><given-names>S</given-names></name>
<name><surname>Welsh</surname><given-names>S</given-names></name>
<name><surname>Liu</surname><given-names>Z</given-names></name>
<name><surname>Freundt</surname><given-names>E</given-names></name>
</person-group>, and others. <year>2006</year>. <article-title>Autophagic programmed cell death by selective catalase degradation</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>103</volume>:<fpage>4952</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr96-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yue</surname><given-names>Z</given-names></name>
<name><surname>Horton</surname><given-names>A</given-names></name>
<name><surname>Bravin</surname><given-names>M</given-names></name>
<name><surname>DeJager</surname><given-names>PL</given-names></name>
<name><surname>Selimi</surname><given-names>F</given-names></name>
<name><surname>Heintz</surname><given-names>N</given-names></name>
</person-group>. <year>2002</year>. <article-title>A novel protein complex linking the delta 2 glutamate receptor and autophagy: implications for neurodegeneration in lurcher mice</article-title>. <source>Neuron</source> <volume>35</volume>:<fpage>921</fpage>–<lpage>33</lpage>.</citation>
</ref>
<ref id="bibr97-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhu</surname><given-names>C</given-names></name>
<name><surname>Wang</surname><given-names>X</given-names></name>
<name><surname>Xu</surname><given-names>F</given-names></name>
<name><surname>Bahr</surname><given-names>BA</given-names></name>
<name><surname>Shibata</surname><given-names>M</given-names></name>
<name><surname>Uchiyama</surname><given-names>Y</given-names></name>
</person-group>, and others. <year>2005</year>. <article-title>The influence of age on apoptotic and other mechanisms of cell death after cerebral hypoxia-ischemia</article-title>. <source>Cell Death Differ</source> <volume>12</volume>:<fpage>162</fpage>–<lpage>76</lpage>.</citation>
</ref>
<ref id="bibr98-1073858411404948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhu</surname><given-names>C</given-names></name>
<name><surname>Xu</surname><given-names>F</given-names></name>
<name><surname>Wang</surname><given-names>X</given-names></name>
<name><surname>Shibata</surname><given-names>M</given-names></name>
<name><surname>Uchiyama</surname><given-names>Y</given-names></name>
<name><surname>Blomgren</surname><given-names>K</given-names></name>
</person-group>, and others. <year>2006</year>. <article-title>Different apoptotic mechanisms are activated in male and female brains after neonatal hypoxia-ischaemia</article-title>. <source>J Neurochem</source> <volume>96</volume>:<fpage>1016</fpage>–<lpage>27</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>